I7
Index
D
DAFN; see Deep anterior femoral nerve
DCIA; see Deep circum ex iliac artery
DDAVP; see Desmopressin acetate
de Quervain’s disease, reoperative peripheral nerve
surgery and, 1990-1991
Debridement
ap failure and, 209
sternal, reoperative surgery of chest wall and,
1539
Debulking, ap, extremity reconstruction and,
2015-2016, 2047-2054
Deep anterior femoral nerve (DAFN), reoperative
peripheral nerve surgery and, 2000
Deep circum ex iliac artery (DCIA), reoperation
for donor site complications and, 168
Deep facial fascia, reoperative rhytidectomy and,
263-264
Deep inferior epigastric perforator (DIEP) ap,
recurrence of breast cancer after recon-
struction with, 1520
Deep temporal fascia, reoperative rhytidectomy
and, 264
Deep vein thrombosis, reoperation following free
ap breast reconstruction and, 1419-1420
Deep-set eye, lateral canthal anchoring and, 560
De ated breasts, reoperation on, after massive-
weight-loss plastic surgery, 1720-1722
De urane (Suprane), secondary rhinoplasty and,
617
Dehiscence
abdominal, lytic phase of wound healing
and, 30
acute wound, reoperative surgery of abdominal
wall and, 1815
levator, complications in eyelid surgery and,
582-583
recurrent pressure sores and, 1828-1829
wound; seeWound dehiscence
Delayed healing, reoperative blepharoplasty and,
452
Delayed primary closure, reoperative surgery of
chest wall and, 1539
Denervation
reoperative plastic surgery and, 24-25
wound healing and, 108
Denver ASPRS Symposium, 224
Depressed patient, 46-47
Depression deformities
correction of, reoperative liposuction and, 1617-
1618, 1626-1628
reoperative surgery of chest wall and, 1587-1589
Dermabrasion
facial aesthetic surgery and, 381-383
nonsurgical scar modi cation and, 123-125
Dermatologic nondisease, body dysmorphic disor-
der and, 61
Desensitization training, patient with pain and, 47
Desmopressin acetate (DDAVP), disorders of clot-
ting factors and, 100
Destroyed Cupid’s bow, at upper lip with, 894-
895
Destroyed eyebrows, reconstruction of burned face
and neck and, 890
Destroyed nasal tip, reconstruction of burned face
and neck and, 893
Diabetes
impaired wound healing and, 117
scars and scar revision and, 113
wound healing and, 108-109
Diabetic neuropathy, wound healing and, 109
DIC; see Disseminated intravascular coagulation
DIEP ap; see Deep inferior epigastric perforator
(DIEP) ap
Digit replantation
incidence of secondary surgery after, 1940
secondary surgery after, 1939
amputation and, 1954
arthrodesis and, 1951
arthroplasty and, 1951
bone grafts and, 1946-1947
capsuloplasty and, 1950-1951
capsulotomy and, 1949-1950
cold intolerance and, 1954
correction of volar joint contracture and,
1945
corrective osteotomy and, 1947
joint reconstruction and, 1949-1951
nerectomy and, 1948
nerve grafts and, 1948
nerve reconstruction and, 1948
neurolysis and, 1948
patient education and, 1941-1943
postoperative care and rehabilitation and,
1955-1958
preoperative planning and, 1941-1943
primary repair and, 1948
procedures for, 1943-1958
pulley reconstruction and, 1953
repair of nonunion and, 1946
skeletal reconstruction and, 1946-1947
skin grafting for small defects and, 1943
skin reconstruction and, 1943-1945
tendon grafting and, 1952-1953
tendon reconstruction and, 1952-1953
tenolysis and, 1952
timing of, 1941-1943
web space releases and, 1944-1945
Digital artery sympathectomy, 1900
Dimensional analysis of facial skeleton, 929
DIP joint; see Distal interphalangeal (DIP) joint
Diprivan; see Propofol
Direct ap measurements, tissue transplantation
in extremity reconstruction and, 2016-
2017
Direct injection, imaging considerations in aug-
mented breast and, 1483-1486
Dirty wounds, reoperative surgery of abdominal
wall and, 1751
Displacement of glabrous neck skin in occipital
region, face-lift techniques and, 242
Disproportion, correction of, reoperative liposuc-
tion and, 1619
Dissatisfaction with body image, body dysmorphic
disorder and, 63-64
Dissatis ed patient, 44-45
Dissection
extended SMAS, 283
of remnant, in ear reconstruction, 766-776
two-layer, closed as single layer, face-lift tech-
niques and, 248-251
Disseminated intravascular coagulation (DIC), dis-
orders of clotting factors and, 101
Distal interphalangeal (DIP) joint, 1874
Distal interphalangeal (DIP) joint arthroplasty, 1891
Distraction, maxillary and mandibular, cleft lip and
cleft lip nasal deformity and, 1042-1045
Distraction osteogenesis and auricular reconstruc-
tion, integration of, 787
Documentation, secondary rhinoplasty and, 605
Dog bite, tissue loss in upper lip as result of, 2062-
2063
Dog-ears, reoperative breast surgery after reduction
mammaplasty and mastopexy and, 1225
Donor materials
manipulation of, reoperative issues following ap
reconstruction in head and, 836
reoperative surgery for nasal reconstruction and,
708-712
secondary rhinoplasty and, 607-608
sources of, secondary rhinoplasty and, 608
Donor site
contracture of, breast reconstruction with pedi-
cled aps and, 1396-1398
optimal, reoperative issues following ap recon-
struction in head and, 834
preparation of, for harvesting, restoration of
fullness to lower eyelid and cheek and,
412-413
problems of, reoperation following free ap
breast reconstruction and, 1465-1473
tightness of, breast reconstruction with pedicled
aps and, 1396-1398
Donor site complications, reoperation for, 147
nonvascularized graft complications and, 148-
151
organ transfers and, 169-170
unsolved problems and, 170-171
vascularized aps and, 151-169
“Donut mastopexy,” body contouring in massive-
weight-loss patient and, 1723
Doppler probes, monitoring ap circulation and,
199
Dorsal capsulotomy, secondary surgery after digit
replantation and, 1949
Dorsal deformities, secondary rhinoplasty and,
624-640
Dorsal graft, visible, secondary rhinoplasty and,
659-665
Dorsal height, failure to perceive loss of, nasal frac-
tures and, 949
Dorsal loss
minimal, secondary rhinoplasty and, 624-630
moderate, secondary rhinoplasty and, 631-636
Dorsal wrist ganglion cyst, reoperative hand sur-
gery and, 1913
Dorsum of foot, reoperative peripheral nerve sur-
gery and, 2002-2003
Double-bubble deformity, reoperative surgery after
breast augmentation and, 1305
Dressing
interval, and coverage, ap failure and, 209
I8
Index
Dressing—cont’d
postoperative, in detection of ap circulation
impairment, 196-198
removal of, in detection of ap circulation im-
pairment, 201-202
Drill-hole xation, reoperative lower lid blepharo-
plasty and, 502
Drugs; see Medications
Dry-eye syndrome, reoperative blepharoplasty and,
450, 451-452
Dupuytren fasciitis, 1868-1879
complications and, 1879
distal interphalangeal joint and, 1874
etiologic factors and, 1869-1870
indications for surgery and, 1873-1874
metacarpophalangeal joint and, 1873
palm surgery and, 1873
patient evaluation and, 1871-1872
postoperative care and, 1878-1879
proximal interphalangeal joint and, 1873-1874
reoperative surgical technique and, 1875-1878
Durant, Ariel, 219
Durant,Will, 219
Dynamic asymmetry, reoperative plastic surgery
and, 26
Dyskinesis of latissimus aps, breast reconstruction
with pedicled aps and, 1396
Dysphagia, reoperative rhytidectomy and, 277
Dystopia
anteroposterior, reoperative craniomaxillofacial
surgery and, 1160
auricular; see Auricular dystopia
vertical, reoperative craniomaxillofacial surgery
and, 1160
Dystopic auricle, reconstruction of, in ear recon-
struction, 778-781
E
Ear
cauli ower, 94
hematomas and, 94
prominent, face-lift result and, 366-368
symmetrical positioning of, reoperation for,
795-797
Ear reconstruction
planning rst stage of, 763
staged sequential procedures for, 759
coverage with temporoparietal fascial ap
and, 784-789
of dystopic auricle, 778-781
fascial aps in, 782
rst-stage transposition of microtic vestige
and, 782-783
of microtia, 760-762
planning rst stage of, 763-776
role of prosthetic reconstruction and, 797
second-stage, 776-777
second-stage placement of augmented auricu-
lar framework and, 784-789
skin and cartilage de ciency with limited
scarring and, 789-792
skin and cartilage de ciency with moderate
and severe scarring and, 792-794
for symmetrical ear positioning, 795-797
third-stage, 777-778
Earlobes
deformities of, face-lift result and, 368-372
forward-displaced, face-lift techniques and, 242
long, face-lift techniques and, 242
Early secondary installation of cartilaginous nasal
framework, 736
Eating disorders, history of, of patient undergoing
cosmetic surgery, 65
Ectropion
of lower lid, reconstruction of burned face and
neck and, 892
of lower lip, reconstruction of burned face and
neck and, 895
postblepharoplasty, causes of, 458
reoperative blepharoplasty and, 458-459
Edema
in ammation and, 115
lid, secondary ptosis correction and, 518
wound healing and, 107
Elbow, ulnar nerve at, reoperative peripheral nerve
surgery and, 1989-1990
Elbow pain, reoperative peripheral nerve surgery
and, 1994
Elevated hairline, reoperative forehead lift and, 325
Elevation of temporal hairline, face-lift techniques
and, 238-241
Elongation of upper lip, face-lift result and, 348-
353
Embolus, pulmonary, reoperation following free
ap breast reconstruction and, 1419-1420
Emotional issues, reoperative rhytidectomy and,
278
Empyema, reoperative surgery of chest wall and,
1565-1566
Encephalocele, frontonasal, reoperative craniomax-
illofacial surgery and, 1160-1161
Endonasal operative approach versus external
operative approach, secondary rhinoplasty
and, 608-609, 616-619
Endoscopy, use of, in reoperative brow-lifting,
333
End-to-side anastomosis, cross-facial nerve grafting
with, 862, 867-869
Epigastrium, bulging, abdominal contouring and,
1656-1657
Epiphora, reoperative blepharoplasty and, 449
Equipment; see Instruments
Error pattern screening articulation test, secondary
cleft palate surgery and, 1061
Ether, face-lift techniques and, 232-233
Excess skin, correction of, reoperative liposuction
and, 1617-1618
Excessive orbital fat excision, reoperative blepharo-
plasty and, 453, 457
Excessive ptosis, free ap breast reconstruction and,
1435-1437
Excessive skin, secondary rhinoplasty and, 652-658
Excision
reconstruction of burned face and neck and,
882-885, 888-899
of upper extremity burns, reoperative surgery
after, 1963-1984
Expanded polytetra uoroethylene (ePTFE), recon-
struction of abdominal wall and, 1755-
1756
Expectations, patient
cosmetic surgery and, 62-63
realistic, de ning, 37
unrealistic, 46-47
Exposed hardware, reoperative issues following ap
reconstruction in head and, 836
Exposure in detection of ap circulation impair-
ment, 204-205
Extended SMAS dissection, 283
External motivations for cosmetic surgery, 62-63
External nasal cover
free tissue transfer for, microsurgical salvage pro-
cedures and, 746-747
loss of, microsurgical salvage procedures and,
746
External operative approach versus endonasal
operative approach, secondary rhinoplasty
and, 608-609, 610-615
“Extreme Makeover,” 55
Extremities
reconstruction of, reoperative surgery following
tissue transplantation in, 2009-2057
direct ap manipulation and, 2016-2017
ap debulking and, 2015-2016, 2047-2054
ap elevation for secondary iliac crest bone
grafting and, 2031-2038
goals of, 2018
Ilizarov application after free tissue transfer
and, 2045-2046
initial considerations for, 2014-2015
planning of, 2014-2018
reoperative procedures for, 2018
secondary nerve grafting and, 2029-2030
secondary tendon reconstruction and, 2020-
2026
staged tendon reconstruction and release of
ap syndactylization and, 2018-2020
tenolysis and, 2026-2028
timing of, 2013-2014
vascular considerations and, 2018
vascularized bone transfer after soft tissue
coverage and, 2038-2044
reoperative surgery of, 1861
after digit replantation, 1939
following tissue transplantation in reconstruc-
tion of, 2009
hand surgery and, 1863
peripheral nerves and, 1985
upper
burns of, 1963
reoperative surgery of, after excision and
grafting of burns of, 1963
Eye
deep-set, lateral canthal anchoring and, 560
prominent; see Prominent eye
Eye ssure shape, complications in eyelid surgery
and, 551-552
Eye prominence, standard, lateral canthal anchoring
and, 559
Eyebrows, destroyed, reconstruction of burned face
and neck and, 890
Eyelid
hematomas and, 95-96
inferior; see Lower eyelid
lower; see Lower eyelid
I9
Index
normal color and texture of, improving, 410-
411
superior; see Upper eyelid
upper; see Upper eyelid
Eyelid asymmetry, secondary ptosis correction and,
518-519
Eyelid edema, secondary ptosis correction and,
518
Eyelid innervation
complications in eyelid surgery and, 546-549
division of innervation of orbicularis and, 548
Eyelid margin irregularities, secondary ptosis cor-
rection and, 518-519
Eyelid mechanics, complications in eyelid surgery
and, 546-549
Eyelid movement, complications in eyelid surgery
and, 546-547
Eyelid region, facial aesthetic surgery and, 386-392
Eyelid surgery, reoperation and avoidance and
treatment of complications in, 545
aesthetic goals in midface area and, 550-567
aesthetic goals in upper lid blepharoplasty and,
577
brow treatment and, 581-582
complications in upper lid and, 586-591
correction of ptosis and, 584-586
differences between nasal and temporal upper lid
and, 578-580
eyelid innervation in, 546-549
eyelid mechanics and, 546-549
lower lid complications and, 568-576
prevention of ptosis and, 582-583
prevention of upper blepharoplasty complica-
tions and, 578
sulcus abnormalities and, 592
treatment of postoperative lagophthalmos and,
586-591
upper lid crease and, 592
F
Face
advancement into deep layers of, face-lift tech-
niques and, 223-224
burned, primary care and secondary reconstruc-
tion of, 881-902
gure H zone of, surgery for recurrent cuta-
neous malignancies of head and neck and,
803
guidelines for restoring contour and surface of,
887
gunshot wound to, reoperative issues following
ap reconstruction in head and, 843-847
Face lift
advancement into deep layers of face and, 223-
224
aesthetic evaluation of patient seeking, 278-281
anesthesia for, 232-233
current technique and, 233-235
lateral edges of platysma and, 223
milestones in evolution of, 219-256
neck and, 236-237
paralysis after, facial reanimation and, 873-874
progress in, 243-252
psychological considerations and, 60
reoperation and, 238-243
role of SMAS in facial rejuvenation surgery and,
231-232
Skoog technique and, 223-224
submental fat pad of neck and, 222-223
suspension of anterior SMAS to fascia above
zygomatic arch and, 225-231
synergy between platysma and SMAS and, 236
technical approaches for, 281
thickness of aps and, 224-225
Face-lift hematoma, prevention of, 93, 94
Face-lift result, adjunctive surgical procedures to
improve, 347
aesthetic rhinoplasty in aging patient and, 364-
366
earlobe deformities and, 368-372
labiomental folds deformity and, 354-358
prominent ears and, 366-368
ptotic chin and, 359-363
reducing fullness of cheek and, 373
“sad pleats” deformity and, 354-358
thinning and elongation of upper lip and, 348-
353
vermilion thinning and, 353
Facial aesthetic surgery
adjunctive procedures to improve results in, 377-
401
analysis of facial aging and, 379
autologous fat transfer and, 380-381
dermabrasion and, 381-383
injectables and, 384-386
lasers and, 381-383
peels and, 381-383
resurfacing tools and, 381-383
botulinum toxin and llers and, 384-386
brow region and, 386-392
eyelid region and, 386-392
perioral region and, 392-398
Facial aging, analysis of, 379
Facial analysis, 598-605
Facial appearance, dramatic changes in, effect of,
on patient, 47
Facial artery musculomucosal (FAMM) ap, ap
reconstruction in head and, 849
Facial expression, muscles of, 262
Facial fascia
deep, reoperative rhytidectomy and, 263-264
super cial, reoperative rhytidectomy and, 261
Facial fractures
with bone and soft tissue loss, 995-999
repair of, reoperative, 903-1011
anatomic considerations and, 906-911
facial fractures with bone and soft tissue loss
and, 995-999
frontal bone fracture and, 932-940
lacrimal obstruction and, 969
LeFort fractures and, 970-983, 986
mandibular fractures and, 985-994
maxillary fractures and, 986
medial canthal and central segment reposi-
tioning and, 945-946
medial canthal injuries and, 940-945
nasal fractures and, 947-951
nasoethmoidal and medial canthal injuries
and, 940-945
orbital fractures and, 952-968
patient evaluation and, 911-913
pediatric fractures and, 994-995
planning and, 915-931
psychosocial considerations and, 913-915
sagittal fractures of maxilla and, 984-985
speci c problems by anatomic region in, 932
zygomatic fractures and, 969-970
Facial grafts, facial reanimation and, 863
Facial injuries, reoperative facial fracture repair
and, 906-907
Facial nerve, reoperative rhytidectomy and, 264-
265
Facial paralysis, congenital, secondary procedures in
facial reanimation and, 870-872
Facial reanimation, secondary procedures and, 859
clinical problem-solving and, 860-870
congenital facial paralysis and, 870-872
denervation of orbicularis oculi muscle and,
872-873
reoperation and, 873-876
timing of, 870
Facial rejuvenation surgery, role of SMAS in, 231-
232
Facial skeleton, dimensional analysis of, 929
Facial soft tissue–skeletal relationships, 922-924
Factor VIII concentrate, disorders of clotting fac-
tors and, 100
Failed aesthetics in implant breast reconstruction,
1352-1359
Failed microsurgical aps, 195
Failed operations, multiple, patient who has had, 48
Failing free ap, reoperation following free ap
breast reconstruction and, 1416-1419
Failing microsurgical aps, 195
Family dynamic, patient and, 41
FAMM ap; see Facial artery musculomucosal
(FAMM) ap
Fasanella-Servat procedure, secondary ptosis cor-
rection and, 521
Fascia
above zygomatic arch, suspension of anterior
SMAS to, 225-231
deep facial, reoperative rhytidectomy and, 263-
264
deep temporal, reoperative rhytidectomy and,
264
investing parotid, reoperative rhytidectomy and,
264
masseteric, reoperative rhytidectomy and, 264
nonvascularized graft complications and, 151
parotidomasseteric, reoperative rhytidectomy
and, 263-264
super cial facial, reoperative rhytidectomy and,
261
super cial investing, 224
temporoparietal, reoperative rhytidectomy and,
265
Fascia sling, secondary ptosis correction and, 519-
520, 523-541
Fascial ap
in ear reconstruction, 782
temporoparietal; seeTemporoparietal fascial ap
vascularized aps and, 152-154
Fascial partition release method, reoperative sur-
gery of abdominal wall and, 1760
I10
Index
Fasciitis, Dupuytren; see Dupuytren fasciitis
Fasciocutaneous aps, vascularized aps and, 152-
154
Fat
augmentation with, imaging considerations in
augmented breast and, 1486
autologous
injections of, into lower lid, complications of,
566-567
transfer of, facial aesthetic surgery and, 380-
381
grafted, removal of, following fat grafting to or-
bital region, 434-435
nonvascularized graft complications and, 150-
151
wound healing and, 108
Fat deposits, abdominal contouring and, 1657-
1664
Fat grafting
to orbital region, prevention of special problems
following, 433-436
reoperative liposuction and, 1615-1616
revisional, of cheek and lower eyelid, 403-439
soft tissue llers and, 127
Fat harvesting and preparation, reoperative liposuc-
tion and, 1614
Fat injection, role of, reoperative forehead lift and,
320-321
Fat necrosis
reoperation following free ap breast recon-
struction and, 1422
reoperative breast surgery after reduction
mammaplasty and mastopexy and, 1212-
1213
Fatty deposits at secondary sites, reoperative lipo-
suction and, 1631-1632
Fatty tissue, restoring, revisional fat grafting of
cheek and lower eyelid and, 407-408
Femoral nerve, reoperative peripheral nerve sur-
gery and, 1998
Femur, proximal, girdlestone resection of, ischial
trochanteric defects and, 1847-1849
Fibrin seal, reoperation between 24 and 48 hours
after injury and, 30
Fibroblasts
collagen-producing, collagen formation and, 29
in ammatory phase of wound healing and, 28
wound healing and, 107
Fibroproliferative phase of wound healing in reop-
erative surgery, 28-29
Figure H zone of face, surgery for recurrent cuta-
neous malignancies of head and neck and,
803
Fillers, facial aesthetic surgery and, 384-386
Financial aspects
of possible complications, 42-44
of reoperation, 82, 84-85
First web space contractures, 1975-1977
First-stage transposition of microtic vestige in ear
reconstruction, 782-783
Fistula
in alveolar region, 1069-1070
hard palate, 1070
intestinal, lytic phase of wound healing and, 30
orocutaneous, lytic phase of wound healing and,
30
palatal; see Palatal stula
parotid, reoperative rhytidectomy and, 276
postalveolar, 1069-1070
postoperative, secondary cleft palate surgery and,
1054
prealveolar, 1069-1070
reoperative surgery of chest wall and, 1566-
1567
repair of, 1066-1067, 1070-1073
secondary cleft palate surgery and, 1055
soft palate, 1070
surgical repair of, 1067-1073
Flank procedures
problems following, 1670-1674
reoperation after liposuction and body contour
surgery and, 1669-1674
Flankplasty
and abdominoplasty, combined, 1674-1675
after liposuction and body contour surgery,
1669-1670, 1682, 1692
Flanks, bulging, abdominal contouring and, 1656-
1657
Flap circulation impairment
detection of
clinical examination in detection of, 198
failed and failing microsurgical aps and,
196-201
operative reexploration in detection of, 203-
209
intraoperative inspection in detection of, 196
nonoperative interventions in detection of,
201-203
postoperative monitoring in detection of, 196-
201
Flap debulking, extremity reconstruction and,
2015-2016, 2047-2054
Flap de ciency, breast reconstruction with pedicled
aps and, 1375-1382, 1392
Flap elevation for secondary iliac crest bone graft-
ing, 2031-2038
Flap failure
recognition and management of, 209
salvage after, 210-213
Flap loss
complete, reoperation following free ap breast
reconstruction and, 1422-1424
partial; see Partial ap loss
small areas of, breast reconstruction with pedi-
cled aps and, 1377
total, breast reconstruction with pedicled aps
and, 1381-1382, 1392
Flap necrosis
hematoma and, 91
recurrent pressure sores and, 1831
Flap reconstruction in head, reoperative issues fol-
lowing, 829
Flap selection options, 212
Flap syndactylization, release of, tissue transplanta-
tion in extremity reconstruction and, 2018-
2020
Flap vessels, alternative, ap circulation impairment
and, 209
Flaps
for abdominal wall coverage, 1761
breast, 197
folded, arteriovenous malformation and, 838-
842
versus grafts, reconstruction after resection of
recurrent cutaneous malignancies of head
and neck and, 810-811
head and neck, 197
hematoma as complication of, 92-94
lower extremity, 197
microsurgical; see Microsurgical aps
monitoring, 198
reconstruction of abdominal wall and, 1761-
1764
thickness of, face-lift techniques and, 224-225
two distinct, face-lift techniques and, 244-247
upper extremity, 197
used in conjunction with breast implants, prob-
lems associated with, 1348
Flaring of alar bases, reconstruction of burned face
and neck and, 893
Flat nasofacial angle, secondary rhinoplasty and,
659-665
Flat upper lip with destroyed Cupid’s bow, recon-
struction of burned face and neck and,
894-895
Flattened chin, reconstruction of burned face and
neck and, 895-896
“Flaying” procedure, reoperative surgery for nasal
reconstruction and, 720-725
Fleur-de-lis excision at nasal base, face-lift result
and, 348-350
Flexor tendon repair and staged grafting, 1915
active prosthetic tendon implants and, 1927
graft rupture repair and, 1925-1926
patient evaluation and, 1916-1917
pulley reconstruction and, 1918-1919
reoperative hand surgery and, 1915
secondary operations and, 1925-1927
stage I repair and, 1917-1920
stage II repair and, 1920-1927
tenolysis and, 1926
Flowmetry, laser Doppler, monitoring ap circula-
tion and, 199, 200
Fluorimetry, quantitative, monitoring ap circula-
tion and, 199, 200
Fluoroethyl, dermabrasion and, 123-125
5-Fluorouracil (5-FU) in management of abnor-
mal scarring, 132
Folded aps, arteriovenous malformation and,
838-842
Foods to be avoided for at least 2 weeks before
surgery, 102-104
Foot, dorsum of, reoperative peripheral nerve sur-
gery and, 2002-2003
Forearm, reoperative peripheral nerve surgery and
median nerve in, 1993-1994
radial nerve in, 1990-1991
Forearm pain, reoperative peripheral nerve surgery
and, 1994-1995
Forehead
paralyzed, from frontal branch injury, reoperative
forehead lift and, 324-325
I11
Index
two-dimensional hypertrophic scars on, recon-
struction of burned face and neck and,
888-889
Forehead lift
primary, basic technique for, 313-318
reoperative, 309-331
basic technique for primary forehead lift and,
313-318
caveats for, 329
elevated hairline and, 325
hair loss and, 322-323
paralyzed forehead from frontal branch injury
and, 324-325
patient evaluation for secondary forehead lift
and, 318
recurrent brow ptosis or asymmetry and, 322
residual rhytids and, 322
role of fat injection and, 320-321
scar depression and contour defects and, 319
subcutaneous forehead lift and, 326-329
unacceptable hairline scar and, 321
unsolved problems and, 330
vascular anatomic considerations and, 311-
313
secondary, patient evaluation for, 318
subcutaneous
postoperative care of, 329
rationale for use of, as reoperative procedure,
326
reoperative forehead lift and, 326-329
technique of, 327-329
Forward-displaced earlobes, face-lift techniques
and, 242
Framework, placement of, in ear reconstruction,
766-776
Free composite nipple graft, reoperative breast sur-
gery after reduction mammaplasty and
mastopexy and, 1204-1211
Free electron laser, nonsurgical scar modi cation
and, 126
Free bula ap, osseous and osteocutaneous aps
and, 168
Free ap, failing, reoperation following free ap
breast reconstruction and, 1416-1419
Free ap breast reconstruction, reoperation follow-
ing, 1411
abdominal ap necrosis and, 1426-1427
breast mound problems and, 1427-1452
complete ap loss and, 1422-1424
complex reconstruction and, 1463-1464
deep vein thrombosis and, 1419-1420
donor site problems and, 1465-1473
excessive ptosis and, 1435-1437
failing free ap and, 1416-1419
fat necrosis and, 1422
goals of, 1416
hematoma and, 1419
infection and, 1421-1422
inframammary fold irregularities and, 1437-
1441
lack of breast mound projection and, 1427-1431
mastectomy ap necrosis and, 1425-1426
nerve injury and, 1473-1474
nipple-areola reconstruction and, 1452-1460
partial ap loss and, 1422-1424
planning and, 1415
pulmonary embolus and, 1419-1420
revisions of reconstructed nipple-areola complex
and, 1461-1462
scars and, 1450-1452
seroma and, 1420-1421
smaller contour defects and, 1441-1449
speci c problems and, 1416-1427
timing of, 1413-1415
upper pole fullness and, 1432-1434
Free aps
for hand reconstruction, 1969
reconstruction of abdominal wall and, 1763-
1764
Free muscle aps, facial reanimation and, 863-864
Free radicals, radiation and, 109
Free tissue transfer
for external nasal cover, microsurgical salvage
procedures and, 746-747
Ilizarov application after, 2045-2046
versus local tissue transfer, reoperative issues fol-
lowing ap reconstruction in head and, 835
for nasal lining; see Nasal lining, free tissue trans-
fer for
postoperative care after, reoperative surgery for
nasal reconstruction and, 754
reoperative craniomaxillofacial surgery and,
1180-1183
Free TRAM ap, recurrence of breast cancer after
reconstruction with, 1520
Frontal bone fracture, reoperative facial fracture re-
pair and, 932-940
Frontal branch injury, paralyzed forehead from, re-
operative forehead lift and, 324-325
Frontalis advancement, upper lid ptosis and, 1179-
1180
Frontonasal encephalocele, reoperative craniomax-
illofacial surgery and, 1160-1161
5-FU; see 5-Fluorouracil
Fullness
of cheek, reducing, face-lift result and, 373
restoration of, to lower eyelid and cheek, 412-
432
Full-thickness graft, reoperative blepharoplasty and,
465
Fusiform excision, scar revision and, 119
G
Gabapentin (Neurontin), patient with pain and,
47
Galeal aps, reoperative craniomaxillofacial surgery
and, 1182-1183
Ganglion cyst
dorsal wrist, reoperative hand surgery and, 1913
volar wrist, reoperative hand surgery and, 1913
Ganglion excision, 1913-1914
complications of, 1914
dorsal wrist ganglion cyst and, 1913
postoperative care and, 1914
reoperative hand surgery and, 1913-1914
surgical technique and, 1913
volar wrist ganglion cyst and, 1913
Gel bleed, breast implant rupture and, 1490
Genetic disorders, radiation and, 109
Geometric broken-line revision,W-plasty and,
122
Giant cell tumor of tendon sheath, 1910
postoperative care and, 1913
reoperative hand surgery and, 1910
surgical technique and, 1912
Giant prosthetic reinforcement of visceral sac
(GPRVS), 1753-1755
Gingival buccal sulcus incision, nasoethmoidal
fracture reduction and stabilization and,
942
Girdlestone resection of proximal femur, ischial
trochanteric defects and, 1847-1849
Glabella, reoperative forehead lift and, 317
Glabrous neck skin, displacement of, in occipital
region into areas normally lled with hair,
242
Glucose, wound healing and, 108
Gluteal ap, reoperation following free ap breast
reconstruction and, 1473
Glycolic acid, scar modi cation and, 127
Goals
of abdominal wall, 1766-1768
of chest wall, 1538-1539
following tissue transplantation in extremity
reconstruction, 2018
of reoperative surgery following free ap breast
reconstruction, 1416
Goldenhar’s syndrome, reoperative craniomaxillo-
facial surgery and, 1166-1168
Gore-Tex, reoperative surgery of abdominal wall
and, 1755-1756
GPRVS; see Giant prosthetic reinforcement of
visceral sac
Graft
alveolar, cleft lip and cleft lip nasal deformity
and, 1040-1042
bone; see Bone grafting
cartilage; see Cartilage grafting
costochondral, reoperative craniomaxillofacial
surgery and, 1178-1179
cranial bone, nasal reconstruction using, 1175-
1178
cross-facial nerve; see Cross-facial nerve grafting
facial reanimation and, 863
fat, soft tissue llers and, 127
versus aps, reconstruction after resection of
recurrent cutaneous malignancies of head
and neck and, 810-811
free composite nipple, reoperative breast surgery
after reduction mammaplasty and
mastopexy and, 1204-1211
full-thickness, reoperative blepharoplasty and,
465
micro-fat, soft tissue llers and, 127
nerve; see Nerve grafting
onlay bone, reoperative craniomaxillofacial sur-
gery and, 1175
reconstruction of burned face and neck and,
882-885, 888-899
revisional fat, of cheek and lower eyelid, 403-
439
skin; see Skin grafting
I12
Index
Graft—cont’d
spacer, reoperative lower lid blepharoplasty and,
503-505
tendon, secondary surgery after digit replanta-
tion and, 1952-1953
of upper extremity burns, reoperative surgery
after, 1963
visible dorsal, secondary rhinoplasty and, 659-
665
webs on neck between normal skin and, recon-
struction of burned face and neck and,
898
wrinkled neck, reconstruction of burned face
and neck and, 897
Graft junctures, hypertrophic scars at, reconstruc-
tion of burned face and neck and, 889
Grafted fat, removal of, following fat grafting to
orbital region, 434-435
Granulation tissue, broproliferative phase of
wound healing and, 29
Groin hernia, recurrent, reoperative surgery of
abdominal wall and, 1817
Groin pain, reoperative peripheral nerve surgery
and, 1996-1997
Groove, alar, reoperative surgery for nasal recon-
struction and, 712-719
Growth retardation of mandible, reconstruction of
burned face and neck and, 897
Gunshot
facial wound from, reoperative issues following
ap reconstruction in head and, 843-847
traumatic loss of abdominal wall from, 1817
H
Hair
delicate, low on neck, absence of, 243
displacement of glabrous neck skin in occipital
region into areas normally lled with, 242
Hair loss, reoperative forehead lift and, 322-323
Hair transplantation
reoperative craniomaxillofacial surgery and,
1129
results of, to temporal region, 241
Hairline
elevated, reoperative forehead lift and, 325
temporal, elevation of, 238-241
use of endoscopy in reoperative brow-lifting
and, 342
Hairline scar, unacceptable, reoperative forehead lift
and, 321
Halocarbon, face-lift techniques and, 233
Hammond procedure, reoperation following free
ap breast reconstruction and, 1455
Hand burns
challenges with, 1965
common sequelae of, 1966
Hand reconstruction, free ap selection for, 1969
Hand reoperation, biologic principles important
to, 1863-1868
Hand resurfacing, pedicle aps for, 1968
Hand surgery, reoperative, 1863
biologic principles important to, 1863-1868
carpal boss syndrome and, 1914-1915
Dupuytren fasciitis and, 1868
exor tendon repair and staged grafting and,
1915
ganglion excision and, 1913-1914
giant cell tumor of tendon sheath and, 1910-
1913
recurrent ischemic ulceration in scleroderma pa-
tients and, 1891
rheumatoid arthritis and, 1879-1891
Hand therapist, role of, 1964
Hand therapy
rehabilitation, principles of, 1964-1965
secondary surgery after digit replantation and,
1955-1958
Hand-held Doppler, monitoring ap circulation
and, 199
Hanging columella, correction of, face lift and,
365-366
Hard palate stulas, 1070
Hardware, exposed, reoperative issues following
ap reconstruction in head and, 836
Harvesting
choice of site of, restoration of fullness to lower
eyelid and cheek and, 412
fat, reoperative liposuction and, 1614
restoration of fullness to lower eyelid and cheek
and, 413-415
Head
ap reconstruction in, reoperative issues follow-
ing, 829
anticipated outcomes and, 855
clinical problem solving and, 834-836
defect evaluation and, 833-834
patient evaluation and, 832-833
planning and, 830
postoperative care and, 854
special considerations and, 853-854
surgical technique and, 836-853
types of patients and, 832-833
types of problems in, 830-831
and neck, recurrent cutaneous malignancies of,
surgery for, 801
gure H zone of face and, 803
melanoma and, 809
patient evaluation and, 807-808
postoperative care and, 821-827
after resection, 810-821
timing of, 804-806
treatment modalities for, 808
and neck, reoperative surgery of, 217, 1194
alloplastic failure and, 1113
burned face and neck and, 881
cleft lip and, 1013
cleft lip nasal deformity and, 1013
cleft palate surgery and, 1053
complications in eyelid surgery and, 545
craniomaxillofacial surgery and, 1139
ear reconstruction and, 759-
face-lift result and, 347
face-lift techniques and, 219
facial aesthetic surgery and, 377
facial fracture repair and, 903
facial reanimation and, 859
ap reconstruction in head and, 829
nasal reconstruction and, 705
recurrent cutaneous malignancies of head and
neck and, 801
reoperative blepharoplasty and, 441
reoperative forehead lift and, 309
reoperative lower lid blepharoplasty and, 481
reoperative rhytidectomy and, 257
revisional fat grafting of cheek and lower eye-
lid and, 403
secondary ptosis correction and, 513
secondary rhinoplasty and, 595
use of endoscopy in reoperative brow-lifting
and, 333
and neck ap, 198
Healing, delayed, reoperative blepharoplasty and,
452
Hematoma, 90-96
auricular, 94
bedside management of, 272
breast, 95
causes of
following surgical procedure, 90
unrelated to surgical procedure, 90
clinical signi cance of, 92-96
complications of, 91-92
ear, 94
face-lift, prevention of, 93, 94
following primary and secondary rhytidectomy,
271
frontal bone fracture and, 939-940
“hidden,” 158
nasal septal, 94
nasal septum, 94
neonatal, 96
operative treatment of, 272-274
organization and, 91
pathophysiology of, 91
recurrent pressure sores and, 1831
reoperation following free ap breast recon-
struction and, 1419
reoperative blepharoplasty and, 448
reoperative breast surgery after reduction
mammaplasty and mastopexy and, 1201-
1202
reoperative plastic surgery and, 16-17
reoperative rhytidectomy and, 272-274
reoperative surgery after breast augmentation
and, 1270-1271
retrobulbar; see Retrobulbar hematoma
septal, 94
TRAM ap and, 158
Hemifacial atrophy, reoperative craniomaxillofacial
surgery and, 1168-1169
Hemifacial microsomia, reoperative craniomaxillo-
facial surgery and, 1149-1150, 1166-1168
Hemophilia A, disorders of clotting factors and,
100
Hemophilia B, disorders of clotting factors and,
100
Hemostasis, wound healing and, 114-115
Heparin
disorders of clotting factors and, 101
failed and failing microsurgical aps and, 202
Herbs to be avoided for at least 2 weeks before
surgery, 102-104
I13
Index
Hernia
breast reconstruction with pedicled aps and,
1387-1389
parastomal, 1817
recurrent groin, reoperative surgery of abdomi-
nal wall and, 1817
TRAM ap and, reoperation following free
ap breast reconstruction and, 1465-
1467
ventral, reoperative surgery of abdominal wall
and, 1816-1817
Heterotopic ossi cation, postoperative, recurrent
pressure sores and, 1830
“Hidden” hematoma,TRAM ap and, 158
High root with unacceptable nasolabial angle,
secondary rhinoplasty and, 684-690
Histamine, in ammation and, 115
History
cosmetic surgery and, 64-66
reoperative blepharoplasty and, 443
reoperative surgery and, 83
secondary rhinoplasty and, 605
Hollowness, axillary, breast reconstruction with
pedicled aps and, 1400-1402
Hospitalization, unplanned, following cosmetic
surgery, insurance for, 42
Hyaluronic acid
in management of abnormal scarring, 128
tear trough and, 391
Hydroxyproline, broproliferative phase of wound
healing and, 28
Hyperbaric oxygen therapy
improved wound healing and, 117
wound healing and, 107
Hypernasality, velopharyngeal insuf ciency and,
1057-1061
Hyperpigmentation
and color mismatch, reconstruction of burned
face and neck and, 899
reoperative blepharoplasty and, 452
Hypertelorism, reoperative craniomaxillofacial
surgery and, 1157-1160
Hypertension, intraabdominal, reoperative surgery
of abdominal wall and, 1770
Hypertrophic scarring, 113, 128, 136
at graft junctures, reconstruction of burned face
and neck and, 889
hand burns and, 1971
reoperative surgery after breast augmentation
and, 1270
two-dimensional, on cheeks and forehead, 888-
889
Hypertrophy, virginal, reoperative breast surgery
after reduction mammaplasty and
mastopexy and, 1253
Hypogastrium, bulging, abdominal contouring
and, 1656-1657
Hypoglossal to facial grafts, facial reanimation and,
863
Hyponasality tests, secondary cleft palate surgery
and, 1061
Hypopigmentation, hand burns and, 1967
Hypoplasia, skeletal, correction of, in treatment of
auricular dystopia, 785-787
I
IAH; see Intraabdominal hypertension
IAP; see Intraabdominal pressure
Iatrogenic aesthetic deformities of lower eyelid and
cheek, 403-406
Ibuprofen, wound healing and, 106
IFN-alpha2b; see Interferon-alpha2b
IFN-gamma in management of abnormal scarring,
132
Iliac crest bone grafting, secondary, ap elevation
for, 2031-2038
Iliac crest free ap, osseous and osteocutaneous
aps and, 168
Iliac crest osseous ap, reoperation for donor site
complications and, 168
Ilium, nonvascularized graft complications and, 149
Ilizarov application after free tissue transfer, 2045-
2046
Ill-de ned tip projection, secondary rhinoplasty
and, 679-683
Imaging considerations in plastic surgery of breast,
1481
Imiquimod 5% cream in management of abnormal
scarring, 132, 133
Immune thrombocytopenic purpura (ITP), platelet
disorders and, 99-100
Immunosuppressive drugs, impaired wound healing
and, 117
Impaired wound healing, 117
Implant
alloplastic, use of, for lower lid spacer support
mechanism, 469-472
breast; see Breast implant
Implantable Doppler probes, monitoring ap cir-
culation and, 199, 200
Improving normal eyelid color and texture, revi-
sional fat grafting of cheek and lower eyelid
and, 410-411
Inadequate anterior excision, lower trunk and,
1726-1727
Inadequate central breast projection, breast recon-
struction with pedicled aps and, 1391
Inadequate lid crease, reoperative blepharoplasty
and, 456-457
Inadequate tip projection and short nasal length,
secondary rhinoplasty and, 691-697
“Inchworm” ap, reoperative plastic surgery and, 8
Incisions
placement of, restoration of fullness to lower
eyelid and cheek and, 412
reoperative blepharoplasty and, 447
reoperative facial fracture repair and, 929-931
reoperative surgery of abdominal wall and, 1769
restoration of fullness to lower eyelid and cheek
and, 418
secondary face lift and, 281-282
Incomplete orbital fat excision, reoperative bleph-
aroplasty and, 453, 457
Increased scleral show, reoperative blepharoplasty
and, 458-459
Indentations, correction of, reoperative liposuction
and, 1619, 1620, 1629-1630
Infected retained recurrent bursa, recurrent pres-
sure sores and, 1832
Infection
arteriovenous malformation and, 838-842
frontal bone fracture and, 939
reoperation following free ap breast recon-
struction and, 1421-1422
reoperative blepharoplasty and, 449-450
reoperative rhytidectomy and, 275-276
reoperative surgery after breast augmentation
and, 1271-1272
wound, wound healing and, 108
Inferior eyelid; see Lower eyelid
Inferior gluteal free ap, muscle and musculocuta-
neous aps and, 166
Inferior orbicularis muscle, vertical reanchoring
of, 573-575
In ltration, level of, restoration of fullness to lower
eyelid and cheek and, 420-421
In ltration cannulas, restoration of fullness to lower
eyelid and cheek and, 419
In ammation
in ammatory phase of wound healing and,
28
wound healing and, 115
In ammatory phase of wound healing in reopera-
tive surgery, 28
Informed consent, 49-51
consultant and, 79
elements required for, 49-51
Inframammary crease laxity, reoperation on, after
massive-weight-loss plastic surgery, 1722-
1723
Inframammary fold
alterations in, reoperation following implant
breast reconstruction and, 1330-1337
correction of, breast reconstruction with pedi-
cled aps and, 1390
irregularities of, reoperation following free ap
breast reconstruction and, 1437-1441
problems of, breast reconstruction with pedicled
aps and, 1392-1393
too high, reoperation following implant breast
reconstruction and, 1331-1335
too low, reoperation following implant breast
reconstruction and, 1336-1337
Infraorbital region
irregularities of, following fat grafting to orbital
region, 433-434
overcorrection in, following fat grafting to or-
bital region, 434
Infrapatellar branch of saphenous nerve (IPBSN),
reoperative peripheral nerve surgery and,
2000
Initial result, unsatisfactory, reoperative facial frac-
ture repair and, 915-917
Injectable soft tissue llers, 127
Injectables, facial aesthetic surgery and, 384-386
Injections
autologous fat, into lower lid, complications of,
566-567
corticosteroid, in management of abnormal scar-
ring, 130-131
fat, reoperative forehead lift and, 320-321
Innervation, eyelid, complications in eyelid surgery
and, 548
I14
Index
“Insatiable” patients, body dysmorphic disorder
and, 61
Inset release in detection of ap circulation impair-
ment, 202
Instruments
for harvesting, restoration of fullness to lower
eyelid and cheek and, 413-414
of head and neck reconstructive surgeons,
834
Insuf cient reduction, breast mound and, reopera-
tive breast surgery after reduction mamma-
plasty and mastopexy and, 1235-1239
Insurance
reoperative surgery and, 82, 84
for unplanned hospitalization following cos-
metic surgery, 42
Integra, reoperative surgery after excision and
grafting of upper extremity burns and,
1970
Interferon-alpha2b (IFN-alpha2b) in management
of abnormal scarring, 131, 133
Interferon-gamma in management of abnormal
scarring, 131
Interleukins in management of abnormal scarring,
132
Internal motivations for cosmetic surgery, 62-63
Interphalangeal joint arthroplasty, proximal, 1888-
1891
Interval dressings and coverage, ap failure and,
209
Interview, secondary rhinoplasty and, 606-607
Intestinal stula, lytic phase of wound healing and,
30
Intolerance, cold, secondary surgery after digit re-
plantation and, 1954
Intraabdominal content, excess, reoperation on,
after massive-weight-loss plastic surgery,
1730-1731
Intraabdominal hypertension (IAH), reoperative
surgery of abdominal wall and, 1770
Intraabdominal pressure (IAP), reoperative surgery
of abdominal wall and, 1770
Intralesional agents in management of abnormal
scarring, 131-132
Intralesional bleomycin in management of abnor-
mal scarring, 132
Intralesional corticosteroids in management of ab-
normal scarring, 136
Intralesional 5- uorouracil in management of ab-
normal scarring, 132
Intralesional interferon-alpha2b in management of
abnormal scarring, 131
Intralesional verapamil in management of abnor-
mal scarring, 132
Intramarginal keloid excisions in management of
abnormal scarring, 135
Inverted V deformity, secondary rhinoplasty and,
642-651
Investing parotid fascia, reoperative rhytidectomy
and, 264
IPBSN; see Infrapatellar branch of saphenous nerve
Ipsilateral ischial pressure sores, 1852
Irradiated breast, reoperative breast surgery after
reduction mammaplasty and mastopexy
and, 1253-1254
Ischemic ulceration, recurrent, in scleroderma pa-
tients, 1891
Ischial pressure sores, 1852-1853
bilateral, 1854-1856
extensive recurrent puborectal, 1849-1850
ipsilateral, 1852
recurrent, 1842-1847
Ischial trochanteric defects after girdlestone resec-
tion of proximal femur, 1847-1849
Iso urane, face-lift techniques and, 233
Isopropyl alcohol, nonvascularized graft complica-
tions and, 150
ITP; see Immune thrombocytopenic purpura
J
Jessner’s solution, scar modi cation and, 127
Joint reconstruction, secondary surgery after digit
replantation and, 1949-1951
K
Keloids, 128
5- uorouracil and, 132
recurrent, reoperative plastic surgery and, 12
scars and scar revision and, 113
YAG laser treatment of, 136
Kenalog; seeTriamcinolone
Knee arthroplasty, reoperative peripheral nerve
surgery and, 1999
Knee pain, reoperative peripheral nerve surgery
and, 1999-2000
Kwashiorkor, wound healing and, 108
L
Labiomental folds deformity, face-lift result and,
354-358
Lacrimal obstruction, reoperative facial fracture
repair and, 969
Lagophthalmos
postoperative, upper eyelid and, 586-591
reoperative blepharoplasty and, 450
upper lid, treatment of, 587-591
Laparotomy, inability to close at, reoperative sur-
gery of abdominal wall and, 1815
Laparotomy wound, open, reoperative surgery of
abdominal wall and, 1815
Large soft tissue de ciency of thighs, reoperative
liposuction and, 1621-1625
Laser Doppler owmetry, monitoring ap circula-
tion and, 199, 200
Lasers
CO 2, nonsurgical scar modi cation and, 126
facial aesthetic surgery and, 381-383
free electron, nonsurgical scar modi cation
and, 126
in management of abnormal scarring, 135-
136
pulsed dye, nonsurgical scar modi cation and,
126
wavelength speci c, scar modi cation and,
126
YAG, nonsurgical scar modi cation and, 126
Lateral arm ap, vascularized aps and, 154
Lateral breast implant displacement, reoperation
following implant breast reconstruction
and, 1339-1342
Lateral canthal anchoring
complications in eyelid surgery and, 549,
553
variations in placement of, 555-561
Lateral canthal tightening procedures, reoperative
lower lid blepharoplasty and, 499-501
Lateral canthopexy, reoperative craniomaxillofacial
surgery and, 1175
Lateral chest wall deformities, reoperative surgery
of chest wall and, 1589-1591
Lateral edges of platysma, face-lift techniques and,
223
Lateral femoral cutaneous nerve (LCFN), re-
operative peripheral nerve surgery and,
2000
Lateral retinacular nerve (LRN), reoperative
peripheral nerve surgery and, 1999-2000
Lateral SMASectomy approach, 287
Lateral trunk excess, reoperation on, after massive-
weight-loss plastic surgery, 1724-1725
Lathyrism, ingestion of sweet peas and, 106
Lathyrogens, wound healing and, 106
Latissimus dorsi ap
breast reconstruction with pedicled aps and,
1373-1374
reoperation after, breast reconstruction with
pedicled aps and, 1391-1402
Latissimus aps, dyskinesis of, breast reconstruction
with pedicled aps and, 1396
LCFN; see Lateral femoral cutaneous nerve
Leeches in detection of ap circulation impair-
ment, 202-203
LeFort fractures, reoperative facial fracture repair
and, 970-983, 986
Lengthening temporalis myoplasty, facial reanima-
tion and, 870
Lessons of History,The, 219
Leukotrienes, in ammation and, 115
Levator advancement, secondary ptosis correction
and, 520, 522
Levator alae nasi muscle, selective resection of,
face-lift result and, 354
Levator dehiscence, mechanism and cause of,
complications in eyelid surgery and,
582-583
Levator shortening, upper lid ptosis and, 1179
Lid asymmetry, secondary ptosis correction and,
518-519
Lid edema, secondary ptosis correction and,
518
Lid malposition, orbital fractures and, 965-968
Lid margin irregularities, secondary ptosis correc-
tion and, 518-519
Lifted breast, imaging considerations in augmented
breast and, 1496-1499
Ligaments, retaining, reoperative rhytidectomy and,
266-267
Lip
bilateral deformity of, cleft lip and cleft lip nasal
deformity and, 1031-1034
lower, ectropion of, reconstruction of burned
face and neck and, 895
unilateral deformity of
cleft, and cleft lip nasal deformity, 1019-
1020
I15
Index
repair of, cleft lip and cleft lip nasal deformity
and, 1020-1022
upper, at, with destroyed Cupid’s bow, recon-
struction of burned face and neck and,
894-895
Lipectomy, suction-assisted, reoperative liposuction
and, 1601
Lipoplasty, ultrasound-assisted, reoperative liposuc-
tion and, 1601
Lipopluction, reoperative surgery for nasal recon-
struction and, 752
Liposuction, 1637-1650
and body contour surgery, reoperation after, 1635
abdominal contouring and, primary operative
approaches to, 1653
buttocks procedures and, 1675-1681
combined ankplasty and abdominoplasty
and, 1674-1675
combined procedures and, 1681-1695
ank procedures and, 1669-1674
intraoperative care and, 1696
patient-physician relationship and, 1636-1637
postoperative care and, 1696
seroma prevention and management follow-
ing abdominoplasty and mini-abdomino-
plasty, 1651-1653
problems following, 1640-1650
psychological aspects of, 59
redo, reoperative liposuction and, 1614
reoperation after, 1637-1650
reoperative, 1601-1634
clinical anatomy of subcutaneous adipose tis-
sue and, 1607
contraindications for, 1610-1612
factors contributing to poor aesthetic results
in, 1602-1606
indications for, 1610-1612
operative techniques and, 1613-1616
outcome of, 1617
postoperative care and, 1616
procedures for treating postliposuction defor-
mities and, 1610
results of, 1617-1632
Lipotransfer, soft tissue llers and, 127
Litigation, costs of reoperative surgery and, 42
Liver disease, coagulation cascade and, 101
Local recurrence of breast cancer after mastectomy
and breast reconstruction, 1511
Local tissue transfer versus free tissue transfer, reop-
erative issues following ap reconstruction
in head and, 835
Long earlobes, face-lift techniques and, 242
Long middle crura, secondary rhinoplasty and,
673-678
Low radix
inadequate tip projection and short nasal length
and, 691-697
secondary rhinoplasty and, 679-683
Lowe, Harry J., 233
Lower abdomen,TRAM ap eventration in, 1817
Lower blepharoplasty, transconjunctival, 482
Lower extremity, reoperative peripheral nerve sur-
gery and, 1998-2003
Lower extremity fasciocutaneous ap, vascularized
aps and, 154
Lower extremity ap, 197
Lower eyelid
anesthesia for, restoration of fullness to lower
eyelid and cheek and, 416
autologous fat injections into, complications of,
566-567
complications and, 550, 568-576
ectropion of, reconstruction of burned face and
neck and, 892
iatrogenic aesthetic deformities of, 403-406
problems and, reoperative blepharoplasty and,
457
providing support to, revisional fat grafting of
cheek and lower eyelid and, 409
restoration of fullness to, 412
retraction of, reoperative blepharoplasty and, 459
revisional fat grafting of, 403
secondary procedures in facial reanimation and,
873
Lower eyelid blepharoplasty, 481
facial aesthetic surgery and, 386
reoperative, 481
complications and, 496-499
patient evaluation and, 483-491
procedural caveats and, 491-496
techniques and, 499-509
Lower eyelid incision, nasoethmoidal fracture re-
duction and stabilization and, 942
Lower eyelid notching, reoperative blepharoplasty
and, 469
Lower eyelid problems, reoperative blepharoplasty
and, 472-473
Lower eyelid retraction, correction of, 459
Lower eyelid retractors, release of, reoperative
lower lid blepharoplasty and, 503
Lower eyelid spacer support mechanism, use of
alloplastic implants for, 469-472
Lower eyelid support, providing, revisional fat
grafting of cheek and lower eyelid and,
409
Lower lid; see Lower eyelid entries
Lower lip, ectropion of, reconstruction of burned
face and neck and, 895
Lower trunk, reoperation on, after massive-weight-
loss plastic surgery, 1724-1731
Low-molecular-weight dextran, failed and failing
microsurgical aps and, 202
LRN; see Lateral retinacular nerve
Lymphatics, reoperative surgery of abdominal wall
and, 1748
Lymphocytes
in ammation and, 115
in ammatory phase of wound healing and, 28
Lyrica; see Pregabalin
Lysosomes, in ammatory phase of wound healing
and, 28
Lytic phase of wound healing in reoperative sur-
gery, 28
M
Macromastia, reoperative surgery of chest wall and,
1527
Macrophages
in ammation and, 115
in ammatory phase of wound healing and, 28
Mafenide (Sulfamylon) cream, skin necrosis and,
158
Magnesium
de ciency of, 117
wound healing and, 106
Major acquired auricular defects, treatment of,
787-788
Malar area, tear trough and, 391
Malar fat pad suspension suture, 288
Malar fat suspension adjuvant to rhytidectomy,
face-lift result and, 354-358
Malar prominence following fat grafting to orbital
region, 436
Malar SMAS dissection, 284
Malignancies, recurrent cutaneous, of head and
neck, surgery for, 801-828
Malnutrition, impaired wound healing and, 117
Malpractice
reoperative plastic surgery and, 48-49
reoperative surgery and, 82
Mammaplasty, reduction, and mastopexy, reopera-
tive breast surgery after, 1197
aesthetic problems and, 1214
anatomic considerations and, 1199-1200
breast mound problems and, 1214
complications and, 1201-1214
irradiated breast and, 1253-1254
nipple-areola complex and, 1240-1247
occult cancer and, 1251-1253
patient evaluation and, 1200
scarring and, 1248-1251
unsolved problems and, 1255
virginal hypertrophy and, 1253
Mammograms after paraf n or silicone injection,
1483-1486
Mandible, growth retardation of, reconstruction of
burned face and neck and, 897
Mandibular distraction, cleft lip and cleft lip nasal
deformity and, 1042-1045
Mandibular fractures
combined, reoperative facial fracture repair and,
992-994
reoperative facial fracture repair and, 986-
994
Mandibular swing approach, reoperative cran-
iomaxillofacial surgery and, 1187-1188
Mandibular/maxillary deformity, correction of,
cleft lip and cleft lip nasal deformity and,
1028-1030
Mannitol, hematoma and, 96
Marginal tarsorrhaphy, reoperative lower lid bleph-
aroplasty and, 498
Markings, reoperative liposuction and, 1613
Massage, patient with pain and, 47
Masseteric cutaneous ligaments, reoperative
rhytidectomy and, 267
Masseteric fascia, reoperative rhytidectomy and,
264
Massive-weight-loss patient
arm complications in, 1734-1735
breast complications in, 1735-1736
breast reoperations in, 1720-1723
combining procedures for, 1706-1719
complications in, 1734-1738
de ated, ptotic breasts in, 1720-1722
I16
Index
Massive-weight-loss patient—cont’d
disparity between thick abdominal ap and line
of closure in, 1728-1729
excess intraabdominal content in, 1730-1731
excess medial thigh skin in, 1732-1733
inadequate anterior excision in, 1726-1727
inframammary crease laxity in, 1722-1723
lateral trunk excess in, 1724-1725
lower trunk operations in, 1724-1731
mons pubis complications in, 1738
reoperations in, 1720-1733
sequencing procedures for, 1706-1719
staging, reoperation, and treatment of complica-
tions after body contouring in, 1701-1740
thigh complications in, 1737-1738
thigh reoperations in, 1732-1733
trunk/ body complications in, 1736-1737
Mastectomy, local recurrence of breast cancer after,
1511
Mastectomy ap necrosis, reoperation following
free ap breast reconstruction and, 1425-
1426
Mastectomy reconstruction, skin-sparing, modi ed
skate ap in, secondary nipple-areola re-
construction and, 1404
Mastopexy
“donut,” body contouring in massive-weight-
loss patient and, 1723
periareolar, capsular contracture of saline im-
plant with, 1307-1308
reduction mammaplasty and, reoperative breast
surgery after, 1197-1259
Matrix production, wound healing and, 116
Maturation phase of wound healing in reoperative
surgery, 29-30
Maxilla, sagittal fractures of, reoperative facial frac-
ture repair and, 984-985
Maxillary distraction, cleft lip and cleft lip nasal
deformity and, 1042-1045
Maxillary fractures, reoperative facial fracture repair
and, 986
Maxillary growth, inhibition of, secondary cleft
palate surgery and, 1055
Maxillary/mandibular deformity, correction of,
cleft lip and cleft lip nasal deformity and,
1028-1030
MCNT; see Medial cutaneous nerve of thigh
Medial canthal and central segment repositioning,
reoperative facial fracture repair and,
945-946
Medial canthal injuries, reoperative facial fracture
repair and, 940-945
Medial canthal ligament, reduction of, using
transnasal wire placement, 944
Medial canthal webs, reconstruction of burned face
and neck and, 892-893
Medial canthopexy, reoperative craniomaxillofacial
surgery and, 1173-1174
Medial cutaneous nerve of thigh (MCNT), reoper-
ative peripheral nerve surgery and, 2000
Medial retinacular nerve (MRN), reoperative pe-
ripheral nerve surgery and, 2000
Medial thigh lift, body contouring in massive-
weight-loss patient and, 1710
Median nerve in forearm, reoperative peripheral
nerve surgery and, 1993-1994
Medical history; see History
Medical record, 51
Medications
cancer chemotherapeutic; see Chemotherapeutic
agents
disorders of clotting factors and, 101
immunosuppressive, impaired wound healing
and, 117
wound healing and, 104-107
Medicolegal considerations, patient and, 48-49
Medpor, reoperative blepharoplasty and, 469, 470,
471
Melanoma, 801
patient evaluation and, 807-808
recurrent, surgery for, 809
Mental health consultation, patients with history of
psychopathology and, 65-66
Mental health referrals of patient undergoing cos-
metic surgery, 66-67
Mental health status of patient undergoing cos-
metic surgery, 64-66
Mersilene, reconstruction of abdominal wall and,
1756
Mesh, Prolene, reconstruction of abdominal wall
and, 1753-1755
Metacarpophalangeal (MP) joint, reoperative sur-
gery and, 1873
Metacarpophalangeal (MP) joint arthroplasty,
1882-1888
complications of, 1887-1888
indications for cross intrinsic transfer at, 1882-
1884
postoperative care and, 1887
revision arthroplasty and, 1886-1887
Swanson arthroplasty and, 1884-1886
Metacarpophalangeal joint contractures, 1972-
1973
Methionine, wound healing and, 108
Microdermabrasion, nonsurgical scar modi cation
and, 123-125
Micro-fat grafts, soft tissue llers and, 127
Microsomia, hemifacial, reoperative craniomaxillo-
facial surgery and, 1149-1150, 1166-1168
Microstomia, reconstruction of burned face and
neck and, 896
Microsurgical aps, failed and failing, 195-216
detection of ap circulation impairment and,
196-201
nonoperative interventions and, 201-203
operative reexploration and, 203-209
recognition and management of ap failure and,
209
salvage after ap failure and, 210-213
Microsurgical salvage procedures in nasal recon-
struction, 746-753
Microtia
classi cation of, 761-762
staged reconstruction of, 760-762
Microtic vestige, rst-stage transposition of, in ear
reconstruction, 782-783
Middle crura, long, secondary rhinoplasty and,
673-678
Midface, dependent bones of, LeFort fractures and,
976
Midface area, aesthetic goals in, complications in
eyelid surgery and, 550-567
Midface lift, reoperative lower lid blepharoplasty
and, 505-507
Mimetic muscles, 262
Miniabdominoplasty
seroma following, 1651-1653
Miniabdominoplasty, reoperation after liposuction
and body contour surgery and
extended, 1659
Miniabdominoplasty, reoperation after liposuction
and body contour surgery and
nonextended, 1658
reoperation after liposuction and body contour
surgery and, 1644, 1657
Minimal deformity, body dysmorphic disorder
and, 61
Minimal dorsal loss, secondary rhinoplasty and,
624-630
Minimally invasive antiaging procedures, 60-61
Minor surgery, avoidance of term of, 50
Missing tissue, assessment of, reoperative issues fol-
lowing ap reconstruction in head and, 833
Moderate dorsal loss, secondary rhinoplasty and,
631-636
Modi ed sh-tail ap, reoperation following free
ap breast reconstruction and, 1455
Modi ed skate ap in skin-sparing mastectomy,
reconstruction
secondary nipple-areola reconstruction and,
1404
Moebius syndrome, secondary procedures in facial
reanimation and, 864, 871-872
Mohs fresh tissue chemosurgery technique, surgery
for recurrent cutaneous malignancies of
head and neck and, 808
Molecular collagen, collagen formation and, 29
Monheit technique, scar modi cation and, 127
Monitoring ap, 198
Monocytes, in ammation and, 115
Mons pubis, complications after body contouring
in massive-weight-loss patient and, 1738
Mood disorders, history of, of patient undergoing
cosmetic surgery, 65-66
Motivation, patient
cosmetic surgery and, 62-63
reoperative surgery and, 43, 46-47
MP joint; see Metacarpophalangeal (MP) joint
MRN; see Medial retinacular nerve
Multiple failed operations, patient who has had, 48
Muscle aps
free, facial reanimation and, 863-864
orthodromic temporal, facial reanimation and,
865-867
temporal, facial reanimation and, 864-865
vascularized aps and, 154-166
Musculocutaneous aps
recurrence of breast cancer after reconstruction
with, 1520
transverse rectus; seeTransverse rectus musculo-
cutaneous ap
vascularized aps and, 154-166
I17
Index
Musculofascial layers, reoperative surgery of ab-
dominal wall and, 1744-1745
Myocutaneous ap reconstruction, local recurrence
of breast cancer after, 1517
Myo broblasts, collagen formation and, 29, 31
Myoplasty, lengthening temporalis, facial reanima-
tion and, 870
N
Narcotics, face-lift techniques and, 232-233
Narrowing the nostrils, face-lift result and, 350
Nasal base, eur-de-lis excision at, face-lift result
and, 348-350
Nasal cover, external
free tissue transfer for, microsurgical salvage pro-
cedures and, 746-747
loss of, microsurgical salvage procedures and,
746
Nasal deformity
cleft lip, secondary corrections for, 1013-1052
secondary, secondary rhinoplasty and, 679-683
traumatic, secondary rhinoplasty and, 636-640
Nasal emission test, secondary cleft palate surgery
and, 1061
Nasal escape, velopharyngeal insuf ciency and,
1057-1061
Nasal fractures
errors in reduction of, 948
failure to perceive loss of dorsal height and, 949
insuf cient mobilization and, 949
reoperative facial fracture repair and, 947-951
Nasal framework, cartilaginous, early secondary
installation of, 736
Nasal half of upper lid versus temporal upper lid,
578-580
Nasal length, short, inadequate tip projection and,
secondary rhinoplasty and, 691-697
Nasal lengthening
nasoethmoidal and medial canthal injuries and,
945
total,Tessier-Wolfe procedure for, 945
Nasal lining
defects of, in subtotal nasal reconstruction, repair
of, 751-753
free tissue transfer for
microsurgical salvage procedures and, 750-
751
reoperative surgery for nasal reconstruction
and, 712
reoperative surgery for nasal reconstruction and,
711-712
Nasal obstruction as testing trap, secondary cleft
palate surgery and, 1063
Nasal reconstruction
microsurgical salvage procedures in, 746-753
reoperative surgery for, 705-757
microvascular salvage procedures in, 746-753
postoperative care after free tissue transfer
and, 754
secondary staged procedures and, 712-745
subtotal nasal reconstruction and, 707-712
total nasal reconstruction and, 707-712
repair of nasal lining defect in, 751-753
subtotal, 707-712
total, 707-712
using cranial bone grafts, 1175-1178
Nasal septal perforation, algorithm for management
of, 621
Nasal septum hematomas, 94
Nasal skin cover, reconstructive options for, 709
Nasal soft tissue envelope, secondary rhinoplasty
and, 622
Nasal tip, destroyed, reconstruction of burned face
and neck and, 893
Nasal tip deformities, secondary rhinoplasty and,
672-683
Nasal tip projection, ill-de ned, secondary rhino-
plasty and, 679-683
Nasoethmoidal fracture (NOE)
loss of septal support and, 944
unilateral, repair of, 941-943
Nasoethmoidal injuries, reoperative facial fracture
repair and, 940-945
Nasofacial angle, at, secondary rhinoplasty and,
659-665
Nasolabial angle, unacceptable, high root with,
secondary rhinoplasty and, 684-690
Nasolabial folds
classi cation of, 393
perioral region and, 392
Neck
burned, primary care and secondary reconstruc-
tion of, 881-902
face-lift techniques and, 236-237
and head, reoperative surgery of; see Head and
neck, reoperative surgery of
recurrent cutaneous malignancies of, surgery for,
801, 828
secondary face lift and, 289-291
submental fat pad of, face-lift techniques and,
222-223
webs on, at junctures between grafts and normal
skin, 898
Neck contractures, reconstruction of burned face
and neck and, 897
Neck grafts, wrinkled, reconstruction of burned
face and neck and, 897
Neck reconstruction, complications in, 831
Neck skin, glabrous, displacement of, in occipital re-
gion into areas normally lled with hair, 242
Necrosis
abdominal ap, reoperation following free ap
breast reconstruction and, 1426-1427
fat
reoperation following free ap breast recon-
struction and, 1422
reoperative breast surgery after reduction
mammaplasty and mastopexy and, 1212-
1213
ap, recurrent pressure sores and, 1831
mastectomy ap, reoperation following free ap
breast reconstruction and, 1425-1426
nipple, reoperative breast surgery after reduction
mammaplasty and mastopexy and, 1203-
1211
umbilical,TRAM ap and, reoperation following
free ap breast reconstruction and, 1468-
1470
Negative pressure wound therapy, use of, in ab-
dominal wall reconstruction, 1765-1766
Neonatal hematoma, 96
Neonatal pelvis, hematomas and, 96
Nerve grafting
cross-facial; see Cross-facial nerve grafting
secondary reoperative surgery following tissue
transplantation in extremity reconstruction,
2029-2030
secondary surgery after digit replantation and,
1948
Nerve injury
reoperation following free ap breast recon-
struction and, 1473-1474
reoperative rhytidectomy and, 277
Nerve reconstruction, secondary surgery after digit
replantation and, 1948
Nerve supply, reoperative surgery of abdominal
wall and, 1748
Nerves, peripheral, reoperative surgery of, 1985-
2007
Neurectomy, secondary surgery after digit replan-
tation and, 1948
Neurolysis, secondary surgery after digit replanta-
tion and, 1948
Neuroma
after breast implant reconstruction, 1352
nonvascularized graft complications and, 150
pain and, 47
Neurontin; see Gabapentin
Neutropenia, wound healing and, 106
Neutrophils, in ammatory phase of wound healing
and, 28
Nicorette gum, face-lift aps and, 231
Nicotine; see Smoking
Nipple graft, free composite, after reduction
mammaplasty and mastopexy and, 1204-
1211
Nipple necrosis, reoperative breast surgery after
reduction mammaplasty and mastopexy
and, 1203-1211
Nipple-areola complex
depigmentation of, 1246
irregular size and shape of, 1246
malposition and, 1240-1245
protrusion of, 1247
reconstructed, revisions of, reoperation follow-
ing free ap breast reconstruction and,
1461-1462
reoperative breast surgery after reduction
mammaplasty and mastopexy and, 1240-
1247
retraction of, 1246
Nipple-areola reconstruction
breast reconstruction with pedicled aps and,
1403-1404
reoperation following free ap breast recon-
struction and, 1452-1460
reoperation following implant breast reconstruc-
tion and, 1346-1347
revisions of, free ap breast reconstruction and,
1461-1462
secondary, breast reconstruction with pedicled
aps and, 1403-1404
I18
Index
Nitrous oxide, face-lift techniques and, 232-233
No re ow, ap failure and, 209
NOE; see Nasoethmoidal fracture
Nonautologous composites used in abdominal wall
repair, 1753
Nonautologous prosthetic materials, reconstruction
of abdominal wall and, 1753-1757
Nonsteroidal antiin ammatory drugs (NSAIDs)
platelet disorders and, 99-100
wound healing and, 106
Nonsurgical scar modi cation, 123-128
Nonunion, repair of, secondary surgery after digit
replantation and, 1946
Nonvascularized graft complications, reoperation
for donor site complications and,
148-151
Nose
bilateral cleft, 1045-1047
bilateral deformity of, cleft lip and cleft lip nasal
deformity and, 1045-1048
cleft, unilateral, secondary correction of, 1024-
1028
cocaine, secondary rhinoplasty and, 619-620
defects involving, reconstruction after resection
of recurrent cutaneous malignancies of
head and neck and, 819-821
short, secondary rhinoplasty and, 684-697
shortened, secondary rhinoplasty and, 666-671
slumped short, correction of, nasoethmoidal and
medial canthal injuries and, 944-945
thick-skinned, secondary rhinoplasty and, 623
thin-skinned, secondary rhinoplasty and, 623-
624
wide, appearance of, reconstruction of burned
face and neck and, 894
Nostrils, narrowing of, face-lift result and, 350
Notching, lower lid, reoperative blepharoplasty
and, 469
NSAIDs; see Nonsteroidal antiin ammatory drugs
Nutrition, wound healing and, 108
O
Oblique transnasal reduction of central fragment,
repair of unilateral nasoethmoidal fractures
and, 941-943
Occipital region
displacement of glabrous neck skin in, into areas
normally lled with hair, 242
retroauricular scar migrating to, face-lift tech-
niques and, 242
Occipitofrontal muscle, reoperative forehead lift
and, 315
Occult breast cancer, reoperative breast surgery
after reduction mammaplasty and
mastopexy and, 1251-1252
Olecranon bursa pressure sores, recurrent, 1850-
1851
Onlay bone grafting, reoperative craniomaxillofa-
cial surgery and, 1175
“On-top” plasty, reoperative surgery after excision
and grafting of upper extremity burns and,
1979-1982
Open capsulotomy for capsular contracture, 1281-
1283
Open laparotomy wound, reoperative surgery of
abdominal wall and, 1815
Opposing vector forces, staging of procedures for
massive-weight-loss patient and, 1705
Optimal donor site, assessment of, reoperative
issues following ap reconstruction in head
and, 834
Orbicularis muscle
division of innervation of, 548
eyelid movement and, complications in eyelid
surgery and, 546-547
inferior, vertical reanchoring of, 573-575
Orbicularis oculi muscle, denervation of, facial
reanimation and, 872-873
Orbicularis suspension, reoperative lower lid
blepharoplasty and, 505-507
Orbit, defects involving, reconstruction after
resection of recurrent cutaneous malig-
nancies of head and neck and, 817-
818
Orbital fat excision, excessive, reoperative bleph-
aroplasty and, 453, 457
Orbital fat excision, incomplete, reoperative bleph-
aroplasty and, 453, 457
Orbital fractures, reoperative facial fracture repair
and, 952-968
Orbital region, fat grafting to, prevention of special
problems following, 433-436
Organ transfers, reoperation for donor site compli-
cations and, 169-170
Orocutaneous stula, lytic phase of wound healing
and, 30
Orthodromic temporal muscle aps, facial reani-
mation and, 865-867
Orthodromic transposition, temporal muscle,
cross-facial nerve grafting with end-to-side
anastomosis plus, 867-869
Osseous aps, vascularized aps and, 167-169
Osteocutaneous ap
reoperation for donor site complications and,
168
vascularized aps and, 167-169
Osteogenesis, distraction, and auricular reconstruc-
tion, integration of, 787
Osteointegration, cleft lip and cleft lip nasal defor-
mity and, 1048-1049
Osteotomy, corrective, secondary surgery after
digit replantation and, 1947
Overcorrection
in infraorbital region, following fat grafting to
orbital region, 434
secondary ptosis correction and, 519-520
Overreduction
breast mound and, reoperative breast surgery
after reduction mammaplasty and
mastopexy and, 1231-1235
skeletal framework, secondary rhinoplasty and,
652-658
Over-the-counter herbal medications, disorders of
clotting factors and, 101, 102-104
Oxygen therapy
face-lift techniques and, 232-233
hyperbaric; see Hyperbaric oxygen therapy
postoperative, face-lift aps and, 231
P
Pain, 47-48
amputation stump, reoperative peripheral nerve
surgery and, 2000
chronic, after breast implant reconstruction, 1352
elbow, reoperative peripheral nerve surgery and,
1994
forearm, reoperative peripheral nerve surgery
and, 1994-1995
groin, reoperative peripheral nerve surgery and,
1996-1997
knee, reoperative peripheral nerve surgery and,
1999-2000
torso, reoperative peripheral nerve surgery and,
1996-1997
wrist, reoperative peripheral nerve surgery and,
1995-1996
Pain clinic, 47
Palatal stula
secondary cleft palate surgery and, 1065-1073
as testing trap, secondary cleft palate surgery
and, 1063
Palatal pushback with pharyngeal ap lining,
velopharyngeal incompetence and, 1082-
1086
Palate repair, residual velopharyngeal incompe-
tence after, 1073-1075
Palm, reoperative surgery and, 1873
Paraf n, imaging considerations in augmented
breast and, 1483-1486
Paralysis
congenital facial, secondary procedures in facial
reanimation and, 870-872
after face lifting, facial reanimation and, 873-874
Paralyzed forehead from frontal branch injury,
reoperative forehead lift and, 324-325
Parastomal hernia, 1817
Parotid capsule, reoperative rhytidectomy and, 264
Parotid stula, reoperative rhytidectomy and, 276
Parotidomasseteric fascia, reoperative rhytidectomy
and, 263-264
“Parrot’s beak,” secondary rhinoplasty and, 652-671
Partial ap loss
breast reconstruction with pedicled aps and,
1392
reoperation following free ap breast recon-
struction and, 1422-1424
Partial thromboplastin time, disorders of clotting
factors and, 100
Partial tissue loss, breast reconstruction with pedi-
cled aps and, 1377-1381
Patient, 35-53
angry, 44
of another surgeon, reoperation on, 82-85
balancing aesthetics with goals and risks, nasal
reconstruction and, 707-708
communication with, 38-41
consultation with, secondary rhinoplasty and,
605-607
de ning realistic expectations and, 37
depressed, 46-47
dissatis ed, 44-45
evaluation of
basal cell carcinoma and, 807-808
I19
Index
breast reconstruction with pedicled aps and,
1367-1369
cosmetic surgery and, 62-67
Dupuytren fasciitis and, 1871-1872
exor tendon repair and staged grafting and,
1916-1917
microsurgical salvage procedures and, 746
plastic surgery of breast and, 1502-1503
Raynaud syndrome and, 1895-1897
recurrent pressure sores and, 1826-1827
reoperative blepharoplasty and, 442-446
reoperative breast surgery after reduction
mammaplasty and mastopexy and, 1200
reoperative facial fracture repair and, 911-913
reoperative issues following ap reconstruction
in head and, 832-833
reoperative lower lid blepharoplasty and, 483-
491
reoperative surgery after breast augmentation
and, 1262-1263
reoperative surgery of chest wall and, 1529-
1536
secondary ptosis correction and, 514-516
silicone-associated problems and, 1288-1293
squamous cell carcinoma and, 807-808
expectations of; see Expectations, patient
family dynamic and, 41
informed consent and, 49-51
“insatiable,” body dysmorphic disorder and, 61
massive-weight-loss; see Massive-weight-loss pa-
tient
medicolegal considerations and, 48-49
motivation of, for reoperative surgery, 43, 46-47
outlining plan and, 42
with pain, 47-48
pediatric; see Pediatric patient
with psychiatric problem, 45-46
refusal of medical professional to treatment of, 67
reoperative environment and, 36-37
searching for another surgeon, 43
terminal cancer, 48
undergoing cosmetic surgery, preoperative evalu-
ation of, 62-67
unrealistic expectations of, 46-47
who has had multiple failed operations, 48
Patient education, secondary surgery after digit re-
plantation and, 1941-1943
Patient positioning
in detection of ap circulation impairment, 201-
202
postoperative, in detection of ap circulation
impairment, 196-198
Patient-physician relationship in reoperative envi-
ronment, 17, 46, 1636-1637
PDGF; see Platelet-derived growth factor
Pectus carinatum, reoperative surgery of chest wall
and, 1587-1589
Pectus excavatum, reoperative surgery of chest wall
and, 1587-1589
Pediatric patient
fractures in, reoperative facial fracture repair and,
994-995
planning chest wall reconstruction for, 1538
Pedicle aps for hand resurfacing, 1968
Peels
chemical; see Chemical peels
facial aesthetic surgery and, 381-383
Pelvis, neonatal, hematomas and, 96
Penicillamine, wound healing and, 106
Periareolar mammaplasty, reoperative breast surgery
and, 1224
Periareolar mastopexy deformity, capsular contrac-
ture of saline implant with, 1307-1308
Periarterial sympathectomy, Raynaud syndrome
and, 1897-1898
Perioral aging, facial aesthetic surgery and, 396
Perioral region, facial aesthetic surgery and, 392-
398
Periosteal ap for lid lengthening, reoperative
lower lid blepharoplasty and, 501
Peripheral nerve surgery, reoperative, 1985-2007
amputation stump pain and, 2000
of brachial plexus, 1988-1989
of dorsum of foot, 2002-2003
elbow pain and, 1994
of femoral nerve, 1998
forearm pain and, 1994-1995
groin pain and, 1996-1997
knee pain and, 1999-2000
lower extremity, 1998-2003
of median nerve in forearm, 1993-1994
of posterior tibial nerve, 2002
postoperative concerns and, 2003
principles of, 1986-1988
of radial nerve in forearm, 1990-1991
recurrent carpal tunnel syndrome and, 1992-
1993
recurrent tarsal tunnel syndrome and, 2001-
2002
of super cial peroneal nerve, 1998
torso pain and, 1996-1997
of ulnar nerve at elbow, 1989-1990
upper extremity, 1988-1996
wrist pain and, 1995-1996
Periumbilicus, bulging, abdominal contouring and,
1656-1657
Perivascular sympathectomy for Raynaud syn-
drome of feet, 1906-1910
Permacol, reoperative surgery of abdominal wall
and, 1758
Peroneal nerve, reoperative peripheral nerve sur-
gery and
common, 1999, 2000
super cial, 1998
Pharyngeal ap
lining of, palatal pushback with, 1082-1086
velopharyngeal incompetence and, 1076-1081
Pharyngeal wall augmentation, posterior, velopha-
ryngeal incompetence and, 1090-1091
Pharyngoplasty, sphincter, velopharyngeal incom-
petence and, 1086-1090
Phenol peels, facial aesthetic surgery and, 381-383
Philtral column de ciency, cleft lip and cleft lip
nasal deformity and, 1023
Phonation test, secondary cleft palate surgery and,
1061
Photographs, preoperative and postoperative,
44-45
Physical therapy, facial reanimation and, 876
Physician-patient relationship in reoperative envi-
ronment, 17, 46, 1636-1637
Pinch test
reoperation after liposuction and body contour
surgery and, 1692
reoperative lower lid blepharoplasty and, 487
Pinching, alar, secondary rhinoplasty and, 666-671
“Pincushioning,” scar realignment and, 119-122
PIP joint; see Proximal interphalangeal (PIP) joint
PIP joint arthroplasty; see Proximal interphalangeal
(PIP) joint arthroplasty
Pixie-ear deformity, adjunctive surgical procedures
to improve face-lift result and, 371, 372
Planned reoperation, 4-9
Planning
breast reconstruction with pedicled aps and,
1369-1371
reoperation following free ap breast recon-
struction and, 1415
reoperative, 17-18, 42
reoperative facial fracture repair and, 915-931
reoperative issues following ap reconstruction
in head and, 830
reoperative surgery following tissue transplanta-
tion in extremity reconstruction, 2014
reoperative surgery of chest wall and, 1536-1538
of staged breast reconstruction, 1319-1325
Plant extracts, disorders of clotting factors and,
101, 102-104
Plastic surgery, reoperative; see Reoperation; Reop-
erative aesthetic and reconstructive plastic
surgery; Reoperative surgery
Platelet aggregation, in ammatory phase of wound
healing and, 28
Platelet disorders, coagulation abnormalities and,
99-100
Platelet growth factors, collagen formation and,
29
Platelet-derived growth factor (PDGF)
collagen formation and, 29
hemostasis and, 115
Platysma
exposure of, along anterior aspect of neck, 289
lateral edges of, face-lift techniques and, 223
and SMAS, synergy between, face-lift techniques
and, 236
Platysma bands, reoperative rhytidectomy and,
270
Pleural space problems, reoperative surgery of chest
wall and, 1565-1587
Plication, aponeurosis, secondary ptosis correction
and, 521-522
PMN cells; see Polymorphonuclear (PMN) cells
Pneumothoraxes, nonvascularized graft complica-
tions and, 149
Pointed chin type, adjunctive surgical procedures
to improve face-lift result and, 361
Poland’s syndrome, 5
imaging considerations in plastic surgery of
breast and, 1482
reoperative surgery of chest wall and, 1589-1591
“Polly beak deformity,” secondary rhinoplasty and,
652-671
I20
Index
Polymethylmethacrylate, secondary procedures in
facial reanimation and, 876
Polymorphonuclear (PMN) cells, in ammation
and, 115
Polytetra uoroethylene, expanded, reconstruction
of abdominal wall and, 1755
Positioning, patient; see Patient positioning
Postalveolar stulas, 1069-1070
Postblepharoplasty ectropion, causes of, 458
Postburn joint problems, chronic, upper extremity,
1972
Postburn reconstruction, upper extremity burns
and, 1965-1970
Posterior pharyngeal wall augmentation, velopha-
ryngeal incompetence and, 1090-1091
Posterior tibial nerve, reoperative peripheral nerve
surgery and, 2002
Postliposuction contour irregularities, 1602
Postliposuction deformities, treatment of, reopera-
tive liposuction and, 1610
Postoperative depression, 46-47
Postoperative lagophthalmos, upper eyelid and,
586-591
Postoperative oxygen therapy, face-lift aps and,
231
Postoperative photographs, reoperative surgery
and, 44-45
Postreplantation surgery
digit, preconditions and postoperative require-
ments for, 1942
incidence of types of, digit replantation and,
1941
Prealveolar stulas, 1069-1070
Pregabalin (Lyrica), patient with pain and, 47
Preoperative photographs, reoperative surgery and,
44-45
Pressure sores
bilateral ischial, 1854-1856
bilateral trochanteric, 1854-1856
concomitant recurrent, 1852-1856
extensive recurrent puborectal ischial, 1849-
1850
ipsilateral ischial, 1852
ischial, 1842-1847, 1849-1850, 1852-1853
olecranon bursa, 1850-1851
puborectal ischial, 1849-1850
recurrent, 1825-1859
chronic wound and, 1832-1856
complications of, 1827-1833
concomitant, 1852-1856
dehiscence and, 1828-1829
ap necrosis and, 1831
hematoma and, 1831
infected retained recurrent bursa and, 1832
ischial trochanteric defects after girdlestone
resection of proximal femur and, 1847-
1849
occurrence of, at other sites, 1829-1830
patient evaluation and, 1826-1827
postoperative heterotopic ossi cation and,
1830
secondary to bony imbalance, 1830
with vacuum-assisted closure device, 1856
sacral, 1832-1839, 1852-1853, 1854-1856
trochanteric, 1839-1842, 1852
Pressure therapy in management of abnormal scar-
ring, 130
Pretunneling, reoperative liposuction and, 1615
Primary care of burned face and neck, 881-902
Primary closure, delayed, reoperative surgery of
chest wall and, 1539
Primary forehead lift, basic technique for, 313-318
Primary rhytidectomy, early complications follow-
ing, 271-305
Primary surgery, how reoperative surgery differs
from, 18-26
Problem surgeon, 85
Problems, patient and, 44-48
Projection, lack of, reoperation following free ap
breast reconstruction and, 1427-1431
Prolene mesh, reconstruction of abdominal wall
and, 1753-1755
Proliferative phase of wound healing, reoperation
during, 31
Prominent ears, face-lift result and, 366-368
Prominent eye
compensatory procedures and, complications in
eyelid surgery and, 563-567
lateral canthal anchoring and, 559, 560
Propofol (Diprivan), secondary rhinoplasty and,
617
Prostacyclins, in ammation and, 115
Prosthetic materials, reconstruction of abdominal
wall and, 1752-1758
autologous, 1757-1758
nonautologous, 1753-1757
Prosthetic reconstruction, role of, ear reconstruc-
tion and, 797
Prosthetic tendon implants, active, exor tendon
repair and staged grafting and, 1927
Protamine sulfate, disorders of clotting factors and,
101
Protein, wound healing and, 108
Protein de ciency, impaired wound healing and,
117
Prothrombin time, disorders of clotting factors
and, 100
Protrusion deformities, reoperative surgery of chest
wall and, 1587-1589
Protuberances, correction of, reoperative liposuc-
tion and, 1617-1618, 1619, 1629-1630
Proximal femur, girdlestone resection of, ischial
trochanteric defects and, 1847-1849
Proximal interphalangeal (PIP) joint, 1873-1874
Proximal interphalangeal (PIP) joint arthroplasty,
1888-1891
complications of, 1891
postoperative care and, 1890
surgical technique and, 1888-1889
swan-neck deformity and, 1889-1890
Proximal interphalangeal (PIP) joint extension
contractures, 1973
Proximal interphalangeal (PIP) joint exion con-
tractures, 1974
Pseudobursa, scapular osteocutaneous ap and, 169
Psychiatric problem, patient with, 45-46
Psychoactive medication, reoperative surgery and,
45-46
Psychological considerations, 55-76
body dysmorphic disorder and, 61-62
of most common cosmetic procedures, 56-61
preoperative evaluation of patient and, 62-67
Psychological expectations; see Expectations, pa-
tient
Psychopathology, patients with history of, preoper-
ative mental health consultation and, 65-66
Psychosocial considerations, reoperative facial frac-
ture repair and, 913-915
Psychotherapist, reoperative surgery and, 45-46
Psychotherapy, reoperation and, 81-82
Ptosis
breast, reoperative plastic surgery and, 14
breast mound and, reduction mammaplasty and
mastopexy and, 1228-1231
of breasts after massive-weight-loss plastic sur-
gery, 1720-1722
brow, use of endoscopy in reoperative brow-lift-
ing and, 341-342
buttock, reoperative liposuction and, 1621-1625
of chin, face-lift result and, 359-363
complications and, 516-520
complications in eyelid surgery and, 582-583,
584-586
correction of, secondary, 513-544
free ap breast reconstruction and, 1435-1437
patient evaluation and, 514-516
recurrent brow, reoperative forehead lift and, 323
reoperative blepharoplasty and, 454-455
saline implant de ation with, breast augmenta-
tion and, 1306
surgical techniques and, 521-541
upper lid, reoperative craniomaxillofacial surgery
and, 1179-1180
Puborectal ischial pressure sores, extensive recur-
rent, 1849-1850
Pulley reconstruction
exor tendon repair and staged grafting and,
1918-1919
secondary surgery after digit replantation and,
1953
Pulmonary embolus, reoperation following free
ap breast reconstruction and, 1419-1420
Pulsed dye laser
in management of abnormal scarring, 136
nonsurgical scar modi cation and, 126
scar modi cation and, 126
Pushback, palatal, with pharyngeal ap lining,
velopharyngeal incompetence and, 1082-
1086
“Pushing scissors” technique, face-lift techniques
and, 222
Q
Quantitative uorimetry, monitoring ap circula-
tion and, 199, 200
R
RA; see Rheumatoid arthritis
Radial forearm ap, vascularized aps and, 152-153
Radial forearm osteocutaneous ap, osseous and
osteocutaneous aps and, 167-168
Radial nerve
compression of, recurrent or persistent, 1990
in forearm, reoperative peripheral nerve surgery
and, 1990-1991
I21
Index
Radiation therapy
abnormal scarring and, 136
impaired wound healing and, 117
reoperative issues following ap reconstruction
in head and, 836-853
surgery for recurrent cutaneous malignancies of
head and neck and, 808-809
wound healing and, 109
Radicals, free, radiation and, 109
Radiologic workup
indications for, silicone-associated problems and,
1291
reoperative craniomaxillofacial surgery and,
1141-1143
Radix, low, secondary rhinoplasty and, 679-683
“Ram’s head deformity,” secondary rhinoplasty
and, 652-671
Random cutaneous aps, vascularized aps and,
151-152
Raynaud disease, 1898
Raynaud phenomenon, 1898
Raynaud syndrome, 159, 1892-1894
Realistic expectations; see Expectations, patient
Reanchoring
canthal, lower lid complications and, 570-573
vertical, of inferior orbicularis muscle, 573-575
Reanimation, facial, secondary procedures in, 859
Recipient vessels
alternative, ap circulation impairment and,
206-208
ap reconstruction in head and, 833
salvage after ap failure and, 212
Reconstruction
abdominal wall, 1765-1766
auricular, and distraction osteogenesis, integra-
tion of, 787
auricular dystopia, temporoparietal fascial ap
in, 784
bone, reoperative issues following ap recon-
struction in head and, 835
bony, reoperative surgery of chest wall and,
1585-1586
breast; see Breast reconstruction
columellar, cleft lip and cleft lip nasal deformity
and, 1034-1036
of deformities after excision and grafting of
acute face and neck burns, 888, 899
ear, staged sequential procedures for, 759-800
of extremities, reoperative surgery following
tissue transplantation in, 2009
ap, in head, reoperative issues following, 829
free ap breast reconstruction and, 1463-1464
hand, free ap selection for, 1969
head and neck, 831
joint, secondary surgery after digit replantation
and, 1949-1951
myocutaneous ap, local recurrence of breast
cancer after, 1517
nasal; see Nasal reconstruction
nerve, secondary surgery after digit replantation
and, 1948
nipple-areolar; see Nipple-areolar reconstruction
postburn, upper extremity burns and, 1965-1970
prosthetic, ear reconstruction and, 797
pulley; see Pulley reconstruction
after resection of recurrent cutaneous malignan-
cies of head and neck, 810
secondary, of burned face and neck, 881-902
of secondary deformities, reconstruction of
burned face and neck and, 885
secondary tendon, reoperative surgery following
tissue transplantation in extremity recon-
struction, 2020-2026
skeletal, secondary surgery after digit replanta-
tion and, 1946-1947
skin, secondary surgery after digit replantation
and, 1943-1945
skin-sparing mastectomy, modi ed skate ap in,
1404
soft tissue, reoperative surgery of chest wall and,
1586-1587
staged tendon, tissue transplantation in extremity
reconstruction and, 2018-2020
tendon, secondary surgery after digit replanta-
tion and, 1952-1953
thumb, 1979-1982
Recontouring, reoperative surgery following tissue
transplantation in extremity reconstruction
and, 2047-2054
Record, medical, 51
Recurrence
of disease, reoperative plastic surgery and,
12-13
local, of breast cancer, after mastectomy and
breast reconstruction, 1511
Recurrent basal cell carcinoma, reoperative plastic
surgery and, 13
Recurrent brow ptosis or asymmetry, reoperative
forehead lift and, 323
Recurrent bursa, infected retained, recurrent pres-
sure sores and, 1832
Recurrent carpal tunnel syndrome, reoperative
peripheral nerve surgery and, 1992-1993
Recurrent cutaneous malignancies of head and
neck, surgery for, 801
Recurrent groin hernia, reoperative surgery of
abdominal wall and, 1817
Recurrent ischemic ulceration in scleroderma pa-
tients, 1891-1910
complications of, 1909-1910
nonsurgical management of, 1894-1895
outcomes of, 1908-1909
pathophysiology of Raynaud syndrome and,
1892-1894
patient evaluation and, 1895-1897
periarterial sympathectomy and, 1897-1898
perivascular sympathectomy for Raynaud syn-
drome of feet and, 1906-1910
postoperative management and, 1908
surgical indications and, 1898-1899
surgical technique and, 1900-1906
Recurrent keloid formation, reoperative plastic
surgery and, 12
Recurrent pressure sores; see Pressure sores, recur-
rent
Recurrent ptosis, breast mound and, 1228-1231
Recurrent scarring, reoperative plastic surgery
and, 12
Recurrent septal perforation, secondary rhinoplasty
and, 621-622
Recurrent tarsal tunnel syndrome, reoperative
peripheral nerve surgery and, 2001-2002
Redo liposuction, reoperative liposuction and,
1614
Redraping, skin, secondary face lift and, 292
Reduction
breast; see Breast reduction
of fullness of cheek, face-lift result and, 373
Reduction mammaplasty and mastopexy, reopera-
tive breast surgery after, 1197
Re nement
reoperative plastic surgery and, 10-12
and transfer, restoration of fullness to lower eye-
lid and cheek and, 416-417
Refrigerants, dermabrasion and, 123-125
Refusal of medical professional to treatment of
patient, 67
Reinsertion, aponeurosis, secondary ptosis correc-
tion and, 521-522
Reirradiation of skull base tumors, reoperative
craniomaxillofacial surgery and, 1188-
1190
Relaxed skin tension lines (RSTLs), scar revision
and, 118-119
Relaxing incision, reconstruction of abdominal
wall and, 1759
Release of lower lid retractors, reoperative lower
lid blepharoplasty and, 503
Remnant, dissection of, in ear reconstruction, 766-
776
Remodeling, wound healing and, 116
Reoperating surgeon and original surgeon, 83-84
Reoperation; see also Reoperative aesthetic and
reconstructive plastic surgery; Reoperative
surgery
on another surgeon’s patient, 82-85
after body contouring in massive-weight-loss
patient, 1701
complications in eyelid surgery and, 545
for donor site complications, 147
establishing reason for, 77-79
face-lift techniques and, 238-243
facial reanimation and, 873-876
nancial aspects of, 82, 84-85
following free ap breast reconstruction, 1411
following implant breast reconstruction, 1317
gathering support for, 79
hand, biologic principles important to, 1863-
1868
if, when, and how to go about, 77-82
importance of listening to patient before,
80-81
after latissimus dorsi ap, breast reconstruction
with pedicled aps and, 1391
after liposuction and body contour surgery,
1635
after massive-weight-loss plastic surgery, 1720,
1733
planned, 4-9
rates of, among patients who have undergone
breast augmentation, 1263
on surgeon’s own patient, 77-82
for symmetrical ear positioning, 795-797
timing of, 82-83
whether or not to schedule, 82-83
I22
Index
Reoperative aesthetic and reconstructive plastic
surgery; see also Reoperation; Reoperative
surgery
of breast and chest wall, 1195
of extremities, 1861-2057
of head and neck, 217-1194
reoperative environment and, 1-86
scars, tissue movement, and transplantation and,
87, 216
of trunk, 1599
Reoperative blepharoplasty, 441
Reoperative breast surgery after reduction
mammaplasty and mastopexy, 1197
Reoperative brow-lifting, use of endoscopy in,
333
Reoperative craniomaxillofacial surgery, 1113,
1137, 1139
Reoperative environment, 1-86
patient-physician relationship in, 1636-1637
patients and, 35-53
psychological considerations and, 55-76
surgeons and, 77-86
what reoperative plastic surgery is, 3, 33
Reoperative facial fracture repair, 903
Reoperative forehead lift, 309
Reoperative hand surgery, 1863
Reoperative issues following ap reconstruction in
head, 829
Reoperative liposuction, 1601
Reoperative lower lid blepharoplasty, 481
Reoperative peripheral nerve surgery, 1985
Reoperative plan, 17-18
Reoperative rhytidectomy, 257
Reoperative surgery; see also Reoperation; Reopera-
tive aesthetic and reconstructive plastic
surgery
of abdominal wall, 1741
adjunctive, to improve face-lift result, 347
of auricle, 788-789
of breast, imaging considerations in, 1481
after breast augmentation, 1261
of chest wall, 1525
complications and, 16-17
continued biologic processes and, 14-15
de nition of, 3
differences of, from primary surgery, 18
after digit replantation, 1939
after excision and grafting of upper extremity
burns, 1963
following tissue transplantation in extremity re-
construction, 2009
goals of, 18
less than satisfactory outcome and, 10
for nasal reconstruction, 705
orbital fractures and, 954-960
planned reoperation and, 4-9
psychological considerations in patients under-
going, 55
recurrence of disease and, 12-13
re nements and, 10-12
reoperative plan and, 17-18
spectrum of, 4-17
touch-ups and, 10-12
wound healing considerations in, 27-31
Reorientation, reoperative surgery following tissue
transplantation in extremity reconstruction
and, 2047-2054
Repeated tissue expansion, 175, 193
Replantation, digit, secondary surgery after, 1939
Resection
of recurrent cutaneous malignancies of head and
neck, reconstruction after, 810
selective, of levator alae nasi muscle, face-lift re-
sult and, 354
Residual rhytids, reoperative forehead lift and,
322
Residual velopharyngeal incompetence after palate
repair, 1073-1075
Restoration
of fatty tissue, revisional fat grafting of cheek
and lower eyelid and, 407-408
of fullness to lower eyelid and cheek, 412
case analysis and, 429-432
massage and, 429
placement technique and, 421-428
postprocedure care and, 428-429
special dressings and, 429
Restylane
facial aesthetic surgery and, 384
psychological considerations and, 60-61
Resurfacing tools, facial aesthetic surgery and, 381-
383
Retained recurrent bursa, infected, recurrent pres-
sure sores and, 1832
Retaining ligaments, reoperative rhytidectomy and,
266-267
Retinacular nerve
lateral, reoperative peripheral nerve surgery and,
1999-2000
medial, reoperative peripheral nerve surgery
and, 2000
Retraction of upper eyelid, reconstruction of
burned face and neck and, 891-892
Retractors, lower lid, release of, reoperative lower
lid blepharoplasty and, 503
Retroauricular scar migrating to occipital region,
face-lift techniques and, 242
Retrobulbar hematoma, 96
eyelid, 95-96
treatment of, 449
Reverse abdominoplasty, autoaugmentation using,
1308-1310
Revision
arthroplasty, 1886-1887
of reconstructed nipple-areola complex, 1461-
1462
Revisional fat grafting of cheek and lower eyelid,
403-439
Rheumatoid arthritis (RA), 1879-1891
arthroplasty and, 1881-1891
biologic mechanism of rheumatoid hand defor-
mity and, 1880-1881
distal interphalangeal joint arthroplasty and,
1891
proximal interphalangeal joint arthroplasty and,
1888-1891
Rheumatoid hand deformity, biologic mechanism
of, 1880-1881
Rhinoplasty
aesthetic, in aging patient, face-lift result and,
364-366
psychological aspects of, 56-57, 60
secondary, 595-703
aesthetic analysis and, 598-605
cocaine nose and, 619-620
documentation and, 605
donor materials and, 607-608
dorsal deformities and, 624-640
endonasal approach to, 616-619
endonasal versus external operative approach
to, 608-609
external approach to, 610-615
nasal soft tissue envelope and, 622
nasal tip deformities and, 672-683
operative approach to, 608-609
patient consultation and, 605-607
postoperative care and, 697-698
re-creation of alar cartilages in, 729-735
recurrent septal perforation and, 621-622
short nose and, 684-697
special considerations of, 619-624
supratip deformities and, 652-671
thick-skinned nose and, 623
thin-skinned nose and, 623-624
timing of, 608
topographic anatomic examination, 596-598
unresolved problems and, 699
vault deformities and, 640-651
Rhytidectomy
malar fat suspension adjuvant to, 354-358
mimetic muscles encountered during, 262
primary, early complications following, 271-
305
psychological considerations and, 60
reoperative, 257-308
aesthetic evaluation of patient seeking sec-
ondary face lift and, 278-281
anatomic considerations and, 259-270
complications and, 257-308
dysphagia and, 277
early complications following primary and
secondary rhytidectomy and, 271-305
emotional issues and, 278
hematomas and, 272-274
infection and, 275-276
nerve injury and, 277
parotid stula and, 276
secondary procedures and, 257-308
skin slough and, 275
technical approaches for secondary face lift
and, 281-305
secondary, early complications following, 271-
305
Rhytids, residual, reoperative forehead lift and,
322
Rib, nonvascularized graft complications and,
149
Root, high, with unacceptable nasolabial angle,
secondary rhinoplasty and, 684-690
Rotation, wide angle of, secondary rhinoplasty and,
673-678
RSTLs; see Relaxed skin tension lines
I23
Index
S
Sacral pressure sores, 1832-1839, 1852-1853,
1854-1856
“Sad pleats” deformity, face-lift result and, 354-
358
Sagittal fractures of maxilla, reoperative facial frac-
ture repair and, 984-985
Sagittal split osteotomy, reoperative facial fracture
repair and, 991
SAL; see Suction-assisted lipectomy
Saldanha’s technique, reoperation after liposuction
and body contour surgery and, 1640
Saline breast implant
capsular contracture of, with periareolar
mastopexy deformity, 1307-1308
correction of problems associated with, 1327-
1330
de ation of, with ptosis, 1306
failure of, 1285-1286
Salvage
after ap failure, 210-213
microsurgical, in nasal reconstruction, 746-753
Saphenous nerve
infrapatellar branch of, reoperative peripheral
nerve surgery and, 2000
nonvascularized graft complications and, 150
Scalp
defects involving, resection of recurrent cuta-
neous malignancies of head and neck and,
814-816
hematomas and, 96
Scalpel, reoperative plastic surgery and, 23
Scapular ap
osteocutaneous, osseous and osteocutaneous
aps and, 169
vascularized aps and, 153
Scarring
abdominal, contouring and, 1657-1664
abnormal, 128
managing, 129-136
surgery for, 133-135
hypertrophic; see Hypertrophic scarring
impaired wound healing and, 117
limited, skin and cartilage de ciency with, ear
reconstruction and, 789-792
malposition of, abdominal contouring and,
1665-1667
moderate and severe, skin and cartilage de -
ciency with, ear reconstruction and, 792-
794
recurrent, reoperative plastic surgery and, 12
reoperation following free ap breast recon-
struction and, 1450-1452
reoperative blepharoplasty and, 452-453
reoperative breast surgery after reduction
mammaplasty and mastopexy and, 1248-
1251
in reoperative versus primary surgery, 18-22
retroauricular, migrating to occipital region,
face-lift techniques and, 242
and scar revision, 113-145
abnormal scarring conditions and, 128
impaired wound healing and, 117
managing abnormal scarring and, 129-136
more complex tissue rearrangements and,
122-123
nonsurgical scar modi cation and, 123-128
scar realignment and, 119-122
surgical principles in scar revision and, 118-
119
timing of scar revision and, 136-137
wound healing and, 114-116
tissue movement and transplantation and, 87
common secondary complications and, 89-
111
failed and failing microsurgical aps and, 195
reoperation for donor site complications and,
147
repeated tissue expansion and, 175-193
and scar revision, 113-145
TRAM ap and, reoperation following free ap
breast reconstruction and, 1471
trapdoor, reoperative facial fracture repair and,
920
unacceptable hairline, reoperative forehead lift
and, 321
Scar contraction, wound healing and, 116
Scar depression, reoperative forehead lift and, 319
Scar modi cation, nonsurgical, 123-128
Scar realignment, wound healing and, 119-122
Scar revision, 113-145
breast reconstruction with pedicled aps and,
1386
potential improvement with, reoperative facial
fracture repair and, 920
surgical principles in, 118-119
timing of, 136-137
SCC; see Squamous cell carcinoma
Schirmer test, reoperative blepharoplasty and, 443
Scissors, face-lift techniques and, 222
Scleral show, increased, reoperative blepharoplasty
and, 458-459
Scleroderma patients, recurrent ischemic ulceration
in, 1891
Scurvy, vitamin C and, 105
Secondary aesthetic rhinoplasty, re-creation of alar
cartilages in, 729-735
Secondary blepharoplasty, secondary ptosis correc-
tion and, 522
Secondary brow lift, reoperative blepharoplasty
and, 475
Secondary cleft palate surgery, 1053
Secondary complications, common, 89
coagulation abnormalities and, 97-104
hematoma and, 90-96
seroma and, 96-97
wound-healing problems and, 104-109
Secondary correction
of cleft lip and cleft lip nasal deformity, 1013
of unilateral cleft nose deformity, 1024-1028
Secondary ap elevation, reoperative surgery for
nasal reconstruction and, 720-725
Secondary forehead lift, patient evaluation for,
318
Secondary iliac crest bone grafting, ap elevation
for, 2031-2038
Secondary installation, early, of cartilaginous nasal
framework, 736
Secondary nasal deformity, secondary rhinoplasty
and, 679-683
Secondary nerve grafting, reoperative surgery fol-
lowing tissue transplantation in extremity
reconstruction, 2029-2030
Secondary nipple-areola reconstruction, breast re-
construction with pedicled aps and, 1403-
1404
Secondary procedures in facial reanimation, 859-
879
Secondary ptosis correction, 513-544
Secondary reconstruction of burned face and
neck, 881
Secondary rhinoplasty, 595-703
Secondary rhytidectomy, early complications fol-
lowing, 271
Secondary staged procedures, reoperative surgery
for nasal reconstruction and, 712
Secondary surgery after digit replantation, 1939
Secondary tendon reconstruction, reoperative sur-
gery following tissue transplantation in ex-
tremity reconstruction, 2020-2026
Segmental subcutaneous lift, reoperative forehead
lift and, 325
Semicircular scars, 116
Sepramesh, reoperative surgery of abdominal wall
and, 1756-1757
Septal hematoma, 94
Septal perforation
nasal, algorithm for management of, 621
recurrent, secondary rhinoplasty and, 621-622
Seroma, 96-97
breast reconstruction with pedicled aps and,
1387
clinical signi cance of, 97
complications of, 97
following abdominoplasty, 96
muscle and musculocutaneous aps and, 155
pathophysiology of, 96
prevention and management of, following
abdominoplasty and miniabdominoplasty,
1651-1653
reoperation following free ap breast recon-
struction and, 1420-1421
reoperative breast surgery after reduction mam-
maplasty and mastopexy and, 1201-1202
reoperative surgery after breast augmentation
and, 1270
TRAM ap and, 158
treatment of, 97
Seventh cranial nerve, 239
Sheeting, silicone, in management of abnormal
scarring, 129
Short nasal length, inadequate tip projection and,
secondary rhinoplasty and, 691-697
Short nose
secondary rhinoplasty and, 684-697
slumped, correction of, nasoethmoidal and me-
dial canthal injuries and, 944-945
Shortened nose, secondary rhinoplasty and, 666-
671
Sickle cell trait, ap surgery and, 1211
Silicone, imaging considerations in augmented
breast and, 1483-1486
I24
Index
Silicone gel sheeting in management of abnormal
scarring, 129
Silicone-associated problems
indications for radiologic workup and, 1291
local symptoms and, 1291-1293
removal of breast implants and, 1293-1294
reoperative surgery after breast augmentation
and, 1288-1300
systemic symptoms and, 1293
total capsulectomy and, 1294-1300
treatment of, 1293-1300
Single midface ap, face-lift techniques and,
243
SIS, reoperative surgery of abdominal wall and,
1757
Skate ap, modi ed, in skin-sparing mastectomy,
secondary nipple-areola reconstruction
and, 1404
Skeletal framework, overreduced, secondary rhino-
plasty and, 652-658
Skeletal hypoplasia, correction of, in treatment of
auricular dystopia, 785-787
Skeletal reconstruction, secondary surgery after
digit replantation and, 1946-1947
Skeletal–soft tissue relationships, facial, reoperative
facial fracture repair and, 922-924
Skeleton, facial, dimensional analysis of, 929
Skin
de ciency of
with limited scarring, ear reconstruction and,
789-792
with moderate and severe scarring, ear recon-
struction and, 792-794
excessive
correction of, reoperative liposuction and,
1617-1618
secondary rhinoplasty and, 652-658
glabrous neck, displacement of, in occipital
region into areas normally lled with hair,
242
nonvascularized graft complications and, 148
normal, webs on neck between grafts and, 898
reoperative rhytidectomy and, 259-260
reoperative surgery of abdominal wall and,
1743-1744
subcutaneous layer of, reoperative rhytidectomy
and, 260
undermining, secondary face lift and, 283
Skin grafting
forcing contour with cartilage grafts under, re-
operative surgery for nasal reconstruction
and, 726-729
hematoma as complication of, 92
for small defects, secondary surgery after digit
replantation and, 1943
Skin laxity, abdominal contouring and, 1657-1664
Skin markings, reoperative blepharoplasty and,
447
Skin reconstruction, secondary surgery after digit
replantation and, 1943-1945
Skin redraping, secondary face lift and, 292
Skin slough, reoperative rhytidectomy and, 275
Skin-sparing mastectomy reconstruction, modi ed
skate ap in, 1404
Skoog technique, face-lift techniques and, 223-
224
Skull base approaches for tumors and tumor recur-
rences, reoperative craniomaxillofacial sur-
gery and, 1184-1190
Skull base tumors, reirradiation of, 1188-1190
Slough, skin, reoperative rhytidectomy and, 275
Slumped short nose, correction of, nasoethmoidal
and medial canthal injuries and, 944-945
Smaller contour defects, reoperation following free
ap breast reconstruction and, 1441-1449
SMAS; see Super cial musculoaponeurotic system
SMAS dissection, malar, 284
SMASectomy approach, lateral, 287
Smoking
effects of, on face-lift aps, 230-231
impaired wound healing and, 117
wound healing and, 106-107
Social expectations, cosmetic surgery and, 63
Soft palate stulas, 1070
Soft tissue coverage
reoperative issues following ap reconstruction
in head and, 835
vascularized bone transfer after, 2038-2044
Soft tissue de ciency, large, of thighs, reoperative
liposuction and, 1621-1625
Soft tissue envelope, nasal, secondary rhinoplasty
and, 622
Soft tissue expansion, 175-193
Soft tissue llers, nonsurgical scar modi cation
and, 127-128
Soft tissue healing, reoperative facial fracture repair
and, 907
Soft tissue injury, reoperative facial fracture repair
and, 908-911
Soft tissue loss, facial fractures with, 995-999
Soft tissue reconstruction, reoperative surgery of
chest wall and, 1586-1587
Soft tissue repositioning, reoperative facial fracture
repair and, 918-919
Soft tissue–skeletal relationships, facial, reoperative
facial fracture repair and, 922-924
SOOP; see Suborbicularis oculi fat
Sores, pressure; see Pressure sores
Space
pleural, problems of, reoperative surgery of chest
wall and, 1565-1587
upper lid blepharoplasty and, 577
Spacer grafts, reoperative lower lid blepharoplasty
and, 503-505
Spacers, lower lid complications and, 576
Speech, evaluation of
from plastic surgeon’s viewpoint, 1056-1065
by speech-language pathologist, secondary cleft
palate surgery and, 1060
Speech prosthesis, velopharyngeal incompetence
and, 1099
Speech therapy, facial reanimation and, 876
Sphincter pharyngoplasty, velopharyngeal incom-
petence and, 1086-1090
Spices to be avoided for at least 2 weeks before
surgery, 102-104
Splinting, postoperative, in detection of ap circu-
lation impairment, 196-198
Squamous cell carcinoma (SCC), 801
patient evaluation and, 807-808
treatment modalities for, 808-809
Square chin type, adjunctive surgical procedures to
improve face-lift result and, 361
Staged breast reconstruction, 1318
Staged facial rejuvenation, secondary face lift and,
293-305
Staged procedures
after body contouring in massive-weight-loss
patient, 1701
for ear reconstruction, 759
reoperative craniomaxillofacial surgery and,
1144-1150
Staged tendon reconstruction, tissue transplanta-
tion in extremity reconstruction and,
2018-2020
Standard eye prominence, lateral canthal anchoring
and, 559
Static asymmetry, reoperative plastic surgery and,
26
Sterile technique, restoration of fullness to lower
eyelid and cheek and, 412-413
Sternal debridement, reoperative surgery of chest
wall and, 1539
Sternal wounds, reoperative surgery of chest wall
and, 1539
Sternotomy, reoperative surgery of chest wall and,
1544-1545
Steroids
impaired wound healing and, 117
in management of abnormal scarring, 130-131
wound healing and, 104
“Stomach stapling,” psychological considerations
and, 59-60
Stoppa, method of, ventral hernias and, 163
Story of Civilization,The, 219
Stranc Plane II frontal impact nasal fractures, 950-
951
Strombeck’s procedure, reoperative breast surgery
after reduction mammaplasty and
mastopexy and, 1246
Subcondylar fracture, reoperative facial fracture
repair and, 991
Subcutaneous adipose tissue, clinical anatomy of,
reoperative liposuction and, 1607
Subcutaneous forehead lift; see Forehead lift, sub-
cutaneous
Subcutaneous hematoma, eyelid, 95-96
Subcutaneous layer of skin, reoperative rhytidec-
tomy and, 260
Subcutaneous tissue, reoperative surgery of abdom-
inal wall and, 1743-1744
Submental fat pad of neck, face-lift techniques
and, 222-223
Suborbicularis oculi fat (SOOF), eyelid surgery
and, 550
Subtotal nasal reconstruction, 707-712, 751-753
Suction-assisted lipectomy (SAL), reoperative lipo-
suction and, 1601
Suicide, relationship between breast implants and,
58-59
Sulcus abnormalities, upper eyelid creases and, 592
Sulfamylon cream; see Mafenide cream
I25
Index
Super cial facial fascia, reoperative rhytidectomy
and, 261
Super cial investing fascia, 224
Super cial musculoaponeurotic system (SMAS),
224
anterior, suspension of, to fascia above zygo-
matic arch, 225-231
and platysma, synergy between, 236
reoperative rhytidectomy and, 261
role of, in facial rejuvenation surgery, 231-232
secondary face lift and, 283-289
Super cial peroneal nerve, reoperative peripheral
nerve surgery and, 1998
Superior eyelid; see Upper eyelid
Suprane; see De urane
Supraplacement, canthal, complications in eyelid
surgery and, 562
Supratip deformities, secondary rhinoplasty and,
652
Surgeon, 77-86
another, patient searching for, 43
limitations of, 48
original, and reoperating surgeon, 83-84
refusal of, to treatment of patient, 67
reoperating, and original surgeon, 83-84
reoperative, implications of wound healing for,
30-31
when patient is someone else’s, 82-85
when patient is your own, 77-82
Surgery, reoperative; see Reoperation; Reoperative
aesthetic and reconstructive plastic surgery;
Reoperative surgery
Surgical antiaging procedures, psychological as-
pects of, 60
Surgical expectations; see Expectations, patient
Surgical history; see History
Surgisis, reoperative surgery of abdominal wall and,
1758
Suture interposition/periosteal ap for lid, 501
Sutures, reconstruction of abdominal wall and,
1759-1761
Swan,The, 55
Swan neck deformity, proximal interphalangeal
joint arthroplasty and, 1889-1890
Swanson arthroplasty, 1884-1886
Symmetrical ear positioning, reoperation for, 795-
797
Symmetry, facial reanimation and, 874-876
Sympathectomy
periarterial, Raynaud syndrome and, 1897-1898
perivascular, for Raynaud syndrome of feet,
1906-1910
Syndactylization, ap, release of, 2018-2020
Synthetic materials, hand burns and, 1970
T
Tarsal strip procedure, reoperative blepharoplasty
and, 461-464
Tarsal tunnel syndrome, recurrent, 2001-2002
Tarsectomy, wedge excision, reoperative blepharo-
plasty and, 461
Tarsorrhaphy, marginal, reoperative lower lid
blepharoplasty and, 498
Tattooed areolar pigmentation, 9, 1462
Tear trough deformity, upper lid, 389
Temporal hairline
elevation of, face-lift techniques and, 238-241
sequence of lowering, 240
Temporal muscle atrophy, reoperative facial fracture
repair and, 924-929
Temporal muscle aps
facial reanimation and, 864-865
orthodromic, facial reanimation and, 865-867
Temporal muscle orthodromic transposition, cross-
facial nerve grafting with end-to-side anas-
tomosis plus, 867-869
Temporal upper lid versus nasal half of upper lid,
578-580
Temporalis myoplasty, lengthening, facial reanima-
tion and, 870
Temporoparietal fascia, reoperative rhytidectomy
and, 265
Temporoparietal fascial ap
in auricular dystopia reconstruction, 784
coverage with, in ear reconstruction, 784-789
vascularized aps and, 154
Tendon, nonvascularized graft complications and,
151
Tendon grafting, secondary surgery after digit re-
plantation and, 1952-1953
Tendon reconstruction
secondary, 2020-2026
secondary surgery after digit replantation and,
1952-1953
Tendon sheath, giant cell tumor of, reoperative
hand surgery and, 1910-1913
Tenolysis
exor tendon repair and staged grafting and,
1926
reoperative surgery following tissue transplanta-
tion in extremity reconstruction, 2026-
2028
secondary surgery after digit replantation and,
1952
Tensor fasciae latae (TFL), reoperative surgery of
abdominal wall and, 1757
Terminal cancer patient, 48
Tessier-Wolfe procedure for total nasal lengthen-
ing, 945
Testing traps, evaluation of speech and, 1063
TFL; seeTensor fasciae latae
TGF-beta; seeTransforming growth factor-beta
The Lessons of History, 219
The Story of Civilization, 219
The Swan, 55
Thick-skinned nose, secondary rhinoplasty and,
623
Thigh
anterior cutaneous nerve of, 2000
complications after body contouring in massive-
weight-loss patient and, 1737-1738
large soft tissue de ciency of, reoperative lipo-
suction and, 1621-1625
medial cutaneous nerve of, 2000
reoperation on, after massive-weight-loss plastic
surgery, 1732-1733
Thigh ap, reoperation following free ap breast
reconstruction and, 1471-1472
Thigh skin, excess medial, reoperation on, after
massive-weight-loss plastic surgery, 1732-
1733
Thighplasty
body contouring in massive-weight-loss patient
and, 1708
inner, after liposuction and body contour sur-
gery, 1692
Thinning
of upper lip, 348-353
vermillion, 353
Thin-skinned nose, secondary rhinoplasty and,
623-624
Three-dimensional modeling, arteriovenous mal-
formation and, 838-842
Thrombin time, disorders of clotting factors and,
100
Thrombosis, deep vein, reoperation following free
ap breast reconstruction and, 1419-1420
Thromboxane A, coagulation and, 98
Thumb, toe transfers to, 170, 204, 1979-1982
Thumb adduction contractures, 1975-1977
Tibial nerve, posterior, reoperative peripheral
nerve surgery and, 2002
Tightness of donor site, breast reconstruction with
pedicled aps and, 1396-1398
Timing
in detection of ap circulation impairment, 203
of reconstruction of microtia, 760
reoperation following free ap breast recon-
struction and, 1413-1415
reoperative blepharoplasty and, 446-447
reoperative surgery after breast augmentation
and, 1263-1264
reoperative surgery following tissue transplanta-
tion in extremity reconstruction, 2013-
2014
reoperative surgery for nasal reconstruction and,
708
reoperative surgery of chest wall and, 1528-1529
secondary procedures in facial reanimation and,
870
secondary rhinoplasty and, 608
secondary surgery after digit replantation and,
1941-1943
of staged breast reconstruction, 1318-1319
surgery for recurrent cutaneous malignancies of
head and neck and, 804-806
Tip projection, inadequate, and short nasal length,
secondary rhinoplasty and, 691-697
Tissue, donor, reoperative issues following ap re-
construction in head and, 836
Tissue characteristics, altered, in reoperative plastic
surgery, 24-25
Tissue excess, breast reconstruction with pedicled
aps and, 1383-1389
Tissue expansion
arteriovenous malformation and, 838-842
reoperative surgery of abdominal wall and, 1766
repeated, 175-193
Tissue aps, autologous, reconstruction of abdomi-
nal wall and, 1760-1761
Tissue loss, partial, breast reconstruction with pedi-
cled aps and, 1377-1381
I26
Index
Tissue movement, scars and transplantation and;
see Scarring, tissue movement and transplan-
tation and
Tissue oxygen de ciency, wound healing and, 107
Tissue rearrangements, more complex, wound heal-
ing and, 122-123
Tissue transfer
free; see Free tissue transfer
local, versus free tissue transfer, reoperative issues
following ap reconstruction in head and,
835
Tissue transplantation
reoperative surgery following, in extremity re-
construction, 2009-2057
scars and tissue movement and; see Scarring,
tissue movement and transplantation and
TNF-alpha in management of abnormal scarring,
132
Tobacco; see Smoking
Toe transfers, 170, 204, 1979-1982
Tonsillectomy, velopharyngeal incompetence and,
1098-1099
Tools; see Instruments
Topical agents in management of abnormal scar-
ring, 132-133
Topographic anatomic examination, secondary
rhinoplasty and, 596-598
Torso pain, reoperative peripheral nerve surgery
and, 1996-1997
Total capsulectomy
for capsular contracture, 1284
silicone-associated problems and, 1294-1300
Total ap loss, breast reconstruction with pedicled
aps and, 1381-1382, 1392
Total nasal lengthening,Tessier-Wolfe procedure
for, 945
Total nasal reconstruction, 707-712
Touch-ups, reoperative plastic surgery and, 10-12
Trace metals, wound healing and, 106
Tracheostomy scar revision, soft tissue repositioning
and, 919
Tragus, blunting of, face-lift techniques and, 241
TRAM ap; seeTransverse rectus abdominis muscu-
locutaneous (TRAM) ap
TRAM ap eventration in lower abdomen, 1817
TRAM ap revision, breast reconstruction with
pedicled aps and, 1371-1373
Transconjunctival lower blepharoplasty, 482
Transforming growth factor-beta (TGF-beta)
collagen formation and, 29
hemostasis and, 115
Transnasal reduction, oblique, of central fragment,
repair of unilateral nasoethmoidal fractures
and, 941-943
Transnasal wire placement, reduction of medial
canthal ligament using, 944
Transplantation; seeTissue transplantation
Transverse rectus abdominis musculocutaneous
(TRAM) ap
muscle and musculocutaneous aps and, 156-165
recontouring, breast reconstruction with pedi-
cled aps and, 1383-1384
recurrence of breast cancer after reconstruction
with, 1520
reoperation following free ap breast recon-
struction and, 1465-1471
repositioning, breast reconstruction with pedi-
cled aps and, 1384-1385
restoration after, breast reconstruction with
pedicled aps and, 1375-1391
Trapdoor scars, reoperative facial fracture repair
and, 920
Trapezius muscle, muscle and musculocutaneous
aps and, 155
Trauma
impaired wound healing and, 117
in ammation and, 116
nasal deformity and, 636-640
Treacher Collins syndrome, reoperative craniomax-
illofacial surgery and, 1154-1157
Triamcinolone (Kenalog)
corticosteroid injections and, 130-131
in management of abnormal scarring, 132
nonvascularized graft complications and, 148
reoperative rhytidectomy and, 292
Tricarboxylic acid, scar modi cation and, 127
Trichloroacetic acid
reoperative blepharoplasty and, 474
scar modi cation and, 127
Trochanteric defects, ischial, after girdlestone resec-
tion of proximal femur, 1847-1849
Trochanteric pressure sores, 1852
bilateral, 1854-1856
recurrent, 1839-1842
Trunk
complications after body contouring in massive-
weight-loss patient and, 1736-1737
lower, reoperation on, after massive-weight-loss
plastic surgery, 1724-1731
reoperative surgery of, 1599-1860
of abdominal wall, 1741-1823
complications after body contouring in mas-
sive-weight-loss patient and, 1701-1740
after liposuction and body contour surgery,
1635-1699
recurrent pressure sores and, 1825-1859
reoperative liposuction and, 1601-1633
Tumor
giant cell, of tendon sheath, reoperative hand
surgery and, 1910-1913
recurrences of, skull base approaches for, 1184-
1190
reoperative craniomaxillofacial surgery and,
1184-1190
reoperative issues following ap reconstruction
in head and, 836-853
skull base, reirradiation of, 1188-1190
Two-dimensional hypertrophic scars on cheeks and
forehead, reconstruction of burned face
and neck and, 888-889
Two-layer dissection closed as single layer, face-lift
techniques and, 248-251
Two-layer ap, face-lift techniques and, 244-247
U
UAL; see Ultrasound-assisted lipoplasty
Ulceration, recurrent ischemic, in scleroderma pa-
tients, 1891-1910
Ulnar nerve at elbow, reoperative peripheral nerve
surgery and, 1989-1990
Ultrapro, reoperative surgery of abdominal wall
and, 1756-1757
Ultrasound-assisted lipoplasty (UAL), reoperative
liposuction and, 1601
Umbilical malposition
abdominal contouring and, 1657-1664
TRAM ap and, reoperation following free ap
breast reconstruction and, 1468-1470
Umbilical necrosis,TRAM ap and, reoperation
following free ap breast reconstruction
and, 1468-1470
Umbilicoplasty, reoperation after liposuction and
body contour surgery and, 1660
Umbilicus, incorrect placement of, 1667-1669
Unacceptable hairline scar, reoperative forehead lift
and, 321
Unacceptable nasolabial angle, high root with, sec-
ondary rhinoplasty and, 684-690
Undercorrection
reoperative blepharoplasty and, 453
secondary ptosis correction and, 519-520
Undermining the skin, secondary face lift and, 283
Unilateral cleft nose deformity, secondary correc-
tion of, 1024-1028
Unilateral deformity, cleft lip and cleft lip nasal de-
formity and, 1018-1030
Unilateral nasoethmoidal fractures, repair of, 941-
943
Unplanned hospitalization following cosmetic sur-
gery, insurance for, 42
Unsatisfactory initial result, reoperative facial frac-
ture repair and, 915-917
Upper extremity, reoperative peripheral nerve sur-
gery and, 1988-1996
Upper extremity burns, reoperative surgery after
excision and grafting of, 1963-1984
bones affected by, 1978-1979
Boutonnière deformity and, 1977-1978
burn scar contractures and, 1966
challenges of burned hand and, 1965
chronic postburn joint problems and, 1972
common sequelae of hand burns and, 1966
complex thumb reconstruction and, 1979-1982
deformities and, 1971-1980
rst web space contractures and, 1975-1977
free ap selection for hand reconstruction and,
1969
hypertrophic scars and, 1971
hypopigmentation and, 1967
joints affected by, 1978-1979
metacarpophalangeal joint contractures and,
1972-1973
pedicle aps for hand resurfacing and, 1968
PIP joint exion contractures and, 1974
postburn reconstruction and, 1965-1970
principles of rehabilitation hand therapy and,
1964-1965
proximal interphalangeal joint extension con-
tractures and, 1973
role of hand therapist and, 1964
severity of contracture and, 1967
soft tissues affected by, 1978-1979
I27
Index
synthetic materials and, 1970
thickness of graft and, 1967
thumb adduction contractions and, 1975-1977
web contractures and, 1975
Upper extremity ap, 197
Upper eyelid
nasal half of, versus temporal upper lid, 578-580
postoperative lagophthalmos and, 586-591
problems and, reoperative blepharoplasty and,
453-457
retraction of, reconstruction of burned face and
neck and, 891-892
secondary procedures in facial reanimation and,
872-873
temporal, versus nasal half of upper lid, 578-580
Upper eyelid blepharoplasty
aesthetic goals in, 577
facial aesthetic surgery and, 386
prevention of complications and, 578
skin excision for, differences between nasal and
temporal upper lid and, 579
Upper eyelid creases, sulcus abnormalities and, 592
Upper eyelid lagophthalmos, treatment of, 587-
591
Upper eyelid margin, position of, upper lid bleph-
aroplasty and, 577
Upper eyelid problems, reoperative blepharoplasty
and, 472-473
Upper eyelid ptosis, reoperative craniomaxillofacial
surgery and, 1179-1180
Upper lid; see Upper eyelid entries
Upper lip
elongation of, face-lift result and, 348-353
at, with destroyed Cupid’s bow, 894-895
thinning of, 348-353
Upper pole fullness, reoperation following free ap
breast reconstruction and, 1432-1434
Uremia, wound healing and, 109
V
Vacuum-assisted closure (VAC)
body contouring in massive-weight-loss patient
and, 1737
reoperative surgery of chest wall and, 1562
treatment of recurrent pressure sores and,
1856
use of, in abdominal wall reconstruction, 1765-
1766
Vaporizers, face-lift techniques and, 232-233
Vascular anatomic considerations, reoperative fore-
head lift and, 311-313
Vascular considerations, reoperative surgery follow-
ing tissue transplantation in extremity
reconstruction, 2018
Vascular supply
reoperative plastic surgery and, 22
reoperative surgery after breast augmentation
and, 1264-1269
reoperative surgery of abdominal wall and,
1746-1747
Vascularized bone transfer after soft tissue coverage,
2038-2044
Vascularized aps, reoperation for donor site com-
plications and, 151-169
Vault deformities, secondary rhinoplasty and,
640-651
VCFS; seeVelocardiofacial syndrome
V-dissector in periorbital region following fat
grafting to orbital region, 436
Vector forces, opposing, staging of procedures for
massive-weight-loss patient and, 1705
Veins
nonvascularized graft complications and, 150
use of type III cannula near, following fat graft-
ing to orbital region, 436
Velocardiofacial syndrome (VCFS), secondary cleft
palate surgery and, 1089-1090
Velopharyngeal incompetence
physical management of, 1075-1099
re-repair of, 1091-1098
residual, after palate repair, 1073-1075
selection criteria for treatment of, 1100-1101
Velopharyngeal insuf ciency
planning treatment for, 1064-1065
primary components of, 1057-1061
secondary cleft palate surgery and, 1055
secondary effects of, 1062-1063
Ventral hernia, reoperative surgery of abdominal
wall and, 1816-1817
Verapamil, intralesional, in management of abnor-
mal scarring, 132
Vermilion border, excision of, face-lift result and,
351-353
Vermilion correction, cleft lip and cleft lip nasal
deformity and, 1023
Vermillion thinning, face-lift result and, 353
Vertical dystopia, reoperative craniomaxillofacial
surgery and, 1160
Vertical reanchoring of inferior orbicularis muscle,
lower lid complications and, 573-575
Vestibular lining elements, loss of, microsurgical
salvage procedures and, 746
Vestige, microtic, rst-stage transposition of, in ear
reconstruction, 782-783
Virginal hypertrophy, reoperative breast surgery
after reduction mammaplasty and masto-
pexy and, 1253
Visible dorsal graft, secondary rhinoplasty and,
659-665
Vision changes, secondary ptosis correction and,
518
Vision loss, reoperative blepharoplasty and, 448-
449
Visual disturbances, orbital fractures and, 961-
965
Visual problems, reoperative blepharoplasty and,
450-451
Vitamin A
de ciency of, 117
wound healing and, 104-105
Vitamin C
de ciency of, 117
wound healing and, 105
Vitamin E, wound healing and, 105
Vitamin K–dependent factors, disorders of clotting
factors and, 100
Vitamins, disorders of clotting factors and, 101,
102-104
Volar joint contracture, secondary surgery after
digit replantation and, 1945
Volar wrist ganglion cyst, reoperative hand surgery
and, 1913
von Willebrand disease, disorders of clotting factors
and, 100
VY advancement lip augmentation, face-lift result
and, 353
Vypro II, reoperative surgery of abdominal wall
and, 1756-1757
W
Warfarin (Coumadin), disorders of clotting factors
and, 101
Wavelength speci c lasers, scar modi cation and,
126
Weaving suspension sutures, 288
Web contractures, hand burns and, 1975
Web space contractures, rst, 1975-1977
Web space releases, secondary surgery after digit
replantation and, 1944-1945
Webs
medial canthal, reconstruction of burned face
and neck and, 892-893
on neck at junctures between grafts and normal
skin, reconstruction of burned face and
neck and, 898
Wedge excision tarsectomy, reoperative blepharo-
plasty and, 461
Wide angle of rotation, secondary rhinoplasty and,
673-678
Wide nose, appearance of, reconstruction of
burned face and neck and, 894
Wire, transnasal, reduction of medial canthal liga-
ment using, 944
Wound dehiscence
acute, reoperative surgery of abdominal wall
and, 1815
breast augmentation and, 1272-1273
reduction mammaplasty and mastopexy and,
1213-1214
Wound healing
common secondary complications of, 104-109
factors affecting, 105, 107-109
impaired, 117
problems of, 104-109
in reoperative surgery, 27-31
scars and, 114-116
Wound infection, wound healing and, 108
Wound vacuum-assisted closure device, reoperative
surgery of chest wall and, 1562
Wounds
abdominal wall defects and, 1751
chronic, recurrent pressure sores and, 1832-1856
chronic phase of, 1750
classi cation of, 1749
clean, 1751
contaminated, 1751
delayed phase of, 1750
dirty, 1751
gunshot, to face, 843-847
immediate phase of, 1749
in ammatory phase of, 1750
open laparotomy, 1815
I28
Index
Wounds—cont’d
secondary ptosis correction and, 516
sternal, 1539-1561
W-plasty, scar realignment and, 121, 124
Wrinkled neck grafts, reconstruction of burned
face and neck and, 897
Wrinkles, use of endoscopy in reoperative brow-
lifting and, 339-341
Wrist ganglion cyst
dorsal, 1913
volar, 1913
Wrist pain, reoperative peripheral nerve surgery
and, 1995-1996
Y
YAG laser, nonsurgical scar modi cation and, 126,
136
Yttrium-aluminum-garnet lasers, scar modi cation
and, 126
YV-plasty, scar realignment and, 122
Z
Zinc
de ciency of, 117
wound healing and, 106
Z-plasty, scar realignment and, 120-121, 122, 124,
135
Zyderm, soft tissue llers and, 127
Zygomatic arch
LeFort fractures and, 977-978
suspension of anterior SMAS to fascia above,
face-lift techniques and, 225-231
Zygomatic fractures, reoperative facial fracture re-
pair and, 969-970
Zygomatic ligaments, reoperative rhytidectomy
and, 266
Zyplast, soft tissue llers and, 127